hemiplegia: Severe or complete loss of motor function on one side of the body. This condition is usually caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness. Less frequently, brain stem lesions; cervical spinal cord diseases; peripheral nervous system diseases; and other conditions may manifest as hemiplegia. The term hemiparesis (see paresis) refers to mild to moderate weakness involving one side of the body. [ MESH:D006429 ]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2086 |
4. Check minimum number of eventsNone |
2086 |
5. Include endpointsNone |
2086 |
6. Filter based on genotype QC (FinnGen only) |
2086 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G80-G83
- Name in latin
- Hemiplegia
Similar endpoints
↥List of similar endpoints to
Hemiplegia
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26668 | 13097 | 13007 |
| Only index persons | 15147 | 8058 | 7089 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.37 | 0.38 | 0.36 |
| Only index persons | 0.28 | 0.30 | 0.27 |
| Median age at first event (years) | |||
| Whole population | 62.63 | 63.06 | 61.95 |
| Only index persons | 52.30 | 51.17 | 53.58 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2086 | 1114 | 972 |
| Unadjusted period prevalence (%) | 0.40 | 0.38 | 0.43 |
| Median age at first event (years) | 52.37 | 46.25 | 59.37 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1921
- Matched controls
- 19221
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G81.9
ICD-10 Finland
Hemiplegia, unspecified
10943.9
323.0
1466
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
7.8
246.6
656
1198
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.8
184.3
470
765
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
+∞
168.2
159
*
AA1AD
NOMESCO Finland
CT of head and brain
4.3
164.6
794
2696
G81.1
ICD-10 Finland
Spastic hemiplegia
391.2
147.1
146
*
3429X
ICD-9 Finland
Hemiplegia, unspecified
+∞
132.9
126
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.3
128.7
380
728
G81.0
ICD-10 Finland
Flaccid hemiplegia
1176.0
114.9
111
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.6
102.5
555
1926
R20.2
ICD-10 Finland
Paraesthesia of skin
5.9
91.2
277
535
R51.80
ICD-10 Finland
Headache
3.8
90.4
450
1439
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.0
86.7
304
692
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
6.5
84.9
236
405
R4120
NOMESCO Finland
Occupational therapy
5.8
81.8
248
475
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.0
81.6
286
648
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.9
77.0
275
634
N03AX12
ATC
gabapentin; oral
3.4
74.9
427
1495
XA800
NOMESCO Finland
Neuropsychological investigation
6.9
73.7
195
311
R4110
NOMESCO Finland
Physiotherapy
2.7
70.5
640
3034
N03AX16
ATC
pregabalin; oral
2.8
69.8
580
2604
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.3
69.1
283
745
M03BX01
ATC
baclofen; systemic
15.4
69.0
116
80
TAB00
NOMESCO Finland
Lumbar puncture
6.3
68.4
193
335
N18
ICPC
Paralysis/weakness
12.0
68.0
128
114
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.9
67.4
199
366
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.4
67.0
215
437
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
65.0
448
1776
R42
ICD-10 Finland
Dizziness and giddiness
2.7
63.3
552
2527
Z3226
NOMESCO Finland
Physiotherapist
2.7
57.8
477
2095
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.1
57.5
193
411
N05BA01
ATC
diazepam; systemic, rectal
3.0
55.3
366
1395
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.4
55.0
152
255
N03AF02
ATC
oxcarbazepine; oral
6.7
54.5
145
231
N03AX09
ATC
lamotrigine; oral
5.4
54.5
173
345
N02AX02
ATC
tramadol; systemic, rectal
2.1
53.5
893
5537
N03AF01
ATC
carbamazepine; oral, rectal
4.7
53.4
194
449
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
4.5
53.2
204
498
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
51.8
668
3674
R53
ICD-10 Finland
Malaise and fatigue
2.5
51.1
507
2444
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
50.7
475
2218
N03AG01
ATC
valproic acid; systemic, rectal
4.2
48.2
198
515
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
48.1
247
778
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
47.9
747
4433
N03AE01
ATC
clonazepam; systemic
4.2
47.2
192
495
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.0
46.6
304
1138
N06AB04
ATC
citalopram; systemic
2.3
46.0
501
2512
N06AX21
ATC
duloxetine; oral
3.2
45.7
268
932
B01AC07
ATC
dipyridamole; systemic
3.9
45.3
203
571
N03AX11
ATC
topiramate; oral
7.3
44.3
110
159
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
44.1
376
1651
G43.9
ICD-10 Finland
Migraine, unspecified
4.3
44.0
174
436
WX892
NOMESCO Finland
Monitored bed care
3.6
43.9
217
661
K90
ICPC
Stroke/cerebrovascular accident
6.3
43.6
120
200
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
43.3
740
4508
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
+∞
42.9
41
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
42.9
41
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
42.8
836
5367
M79.6
ICD-10 Finland
Pain in limb
2.1
42.7
705
4232
L28
ICPC
Limited function/disability (L)
2.5
42.7
375
1672
Z2446
NOMESCO Finland
Social worker
3.6
42.2
203
605
Z2445
NOMESCO Finland
Psychologist
5.0
41.9
142
304
N06AA09
ATC
amitriptyline; systemic
3.0
41.0
260
950
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.9
40.8
141
308
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.7
40.6
145
328
TKC20
NOMESCO Finland
Catheterisation of bladder
3.4
40.3
214
688
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
39.4
316
1335
Z3231
NOMESCO Finland
Registered nurse
2.1
39.3
583
3321
G44.2
ICD-10 Finland
Tension-type headache
2.7
39.0
304
1261
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
38.9
236
835
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.7
38.6
182
532
R06.0
ICD-10 Finland
Dyspnoea
2.1
38.3
524
2880
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
38.2
230
807
N06AX11
ATC
mirtazapine; oral
2.0
37.7
635
3794
S06.0
ICD-10 Finland
Concussion
2.8
37.5
263
1020
R55
ICD-10 Finland
Syncope and collapse
2.7
37.2
277
1117
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.2
37.2
104
177
N05AH04
ATC
quetiapine; oral
2.4
36.5
363
1715
Z2221
NOMESCO Finland
Medical doctor
2.0
36.4
584
3415
A28
ICPC
Limited function/disability NOS
2.4
36.3
352
1642
N06AX16
ATC
venlafaxine; oral
2.6
36.3
295
1251
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
35.2
774
5077
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
34.6
553
3216
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.5
34.5
309
1380
G43.3
ICD-10 Finland
Complicated migraine
8.5
34.1
76
93
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.0
33.7
85
126
N05CF01
ATC
zopiclone; oral
1.9
33.2
672
4257
AA5PD
NOMESCO Finland
CT examination of brain pefusion
12.9
33.1
59
47
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
32.5
258
1074
N03AX14
ATC
levetiracetam; systemic
5.6
32.4
97
180
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.8
32.4
145
405
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
32.3
428
2296
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
16.2
32.1
52
33
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.6
31.4
82
128
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
6.4
31.3
84
136
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
31.2
573
3486
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.6
31.2
82
129
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
31.1
378
1945
B01AC04
ATC
clopidogrel; oral
2.3
30.9
340
1674
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
30.8
326
1576
R1250
NOMESCO Finland
Evaluation of functional capability
6.5
30.5
81
129
M54.5
ICD-10 Finland
Low back pain
1.9
30.2
613
3858
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
7.9
30.1
70
92
M54.4
ICD-10 Finland
Lumbago with sciatica
2.2
29.8
332
1640
N28
ICPC
Limited function/disability (N)
7.6
29.8
71
97
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
29.7
350
1775
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
29.6
521
3111
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.6
29.6
105
236
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
29.4
334
1667
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.1
28.6
353
1825
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
28.5
313
1534
A06AD11
ATC
lactulose; oral
2.1
28.4
350
1808
N02AA05
ATC
oxycodone; systemic
2.2
27.7
310
1534
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
27.5
209
844
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
27.4
439
2517
N05BA04
ATC
oxazepam; oral
1.9
27.4
499
2999
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.2
27.2
107
266
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
27.0
359
1912
G35
ICD-10 Finland
Multiple sclerosis
6.6
26.9
70
109
A02BC02
ATC
pantoprazole; systemic
1.7
26.9
1159
9089
SPAT1229
SPAT
Assessment of need for aid
2.7
26.6
194
764
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
26.6
231
1006
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
9.4
26.5
55
60
183
Kela drug reimbursment
Lamotrigin and topiramate
9.7
26.5
54
57
N03AB02
ATC
phenytoin; systemic
9.0
26.3
56
64
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
26.2
198
797
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
26.2
361
1950
ZXE00
NOMESCO Finland
One hour or less
1.7
26.1
743
5154
ZXD05
NOMESCO Finland
Urgent procedure
1.8
25.7
601
3917
H53.1
ICD-10 Finland
Subjective visual disturbances
3.0
25.4
151
523
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.7
25.4
184
723
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
8.9
25.3
54
62
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
25.3
180
700
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.6
25.2
75
139
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.6
25.2
119
348
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
25.1
158
567
3431A
ICD-9 Finland
Infantile cerebral palsy, Hemiplegic
+∞
25.0
24
*
G43.8
ICD-10 Finland
Other migraine
7.6
25.0
59
80
N05CD07
ATC
temazepam; oral
2.1
24.9
307
1577
H53.4
ICD-10 Finland
Visual field defects
5.2
24.6
78
156
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
9.0
24.6
52
59
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
7.5
24.5
58
79
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
8.1
24.3
55
70
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.2
24.2
59
84
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.8
24.0
44
38
N30.0
ICD-10 Finland
Acute cystitis
2.1
24.0
286
1447
N06AB10
ATC
escitalopram; oral
2.0
23.9
373
2103
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
23.8
349
1926
J01MA02
ATC
ciprofloxacin; systemic
1.7
23.5
727
5118
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.7
23.4
104
289
F10.09
ICD-10 Finland
Alcohol intoxication UNS
5.9
23.4
66
115
M54.1
ICD-10 Finland
Radiculopathy
3.7
23.3
104
290
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.3
23.3
123
392
R51
ICD-10 Finland
Headache
3.4
23.2
118
366
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.7
23.1
105
298
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.9
23.1
151
557
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
23.0
22
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.8
22.9
66
118
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.0
22.8
138
484
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.9
22.8
52
67
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
5.5
22.8
68
127
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
5.6
22.7
67
123
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
121.5
22.6
24
*
N06AB03
ATC
fluoxetine; oral
2.2
22.6
253
1243
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
8.3
22.5
50
62
J01EA01
ATC
trimethoprim; systemic
1.8
22.2
503
3217
C03CA01
ATC
furosemide; systemic
1.7
22.2
594
3997
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
22.2
221
1030
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
22.1
402
2393
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
21.7
306
1657
R11
ICD-10 Finland
Nausea and vomiting
2.5
21.6
172
714
J01FF01
ATC
clindamycin; systemic
1.8
21.6
487
3108
R02
ICPC
Shortness of breath/dyspnoea
2.2
20.9
229
1113
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.4
20.9
77
181
R52.2
ICD-10 Finland
Other chronic pain
4.1
20.8
83
210
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
20.8
377
2234
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
20.8
473
3020
N05BA09
ATC
clobazam; oral
13.7
20.5
35
26
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
20.3
698
5005
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
8.0
20.3
46
59
H53.2
ICD-10 Finland
Diplopia
4.1
20.2
81
206
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.5
20.2
162
671
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
20.2
797
5917
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.9
20.2
130
474
315
Kela drug reimbursment
Clopidogrel
7.2
20.2
49
70
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.5
20.1
163
683
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.0
20.1
120
417
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.0
20.0
119
411
M25.5
ICD-10 Finland
Pain in joint
1.7
19.9
484
3148
C10AA05
ATC
atorvastatin; oral
1.6
19.8
630
4418
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.8
19.7
67
145
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.1
19.7
48
69
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
19.6
273
1467
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
5.0
19.5
63
129
N99
ICPC
Neurological disease other
7.2
19.4
47
67
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
19.4
372
2246
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.0
19.3
117
411
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.2
19.3
74
181
L17
ICPC
Foot/toe symptom/complaint
1.7
19.3
433
2744
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.3
19.3
182
824
K91
ICPC
Cerebrovascular disease
6.2
19.3
52
86
H02AB06
ATC
prednisolone; systemic
1.6
19.1
831
6291
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.7
19.1
55
99
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
14.1
19.1
32
23
F44.4
ICD-10 Finland
Dissociative motor disorders
34.7
18.9
24
7
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
18.9
89
261
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
9.7
18.9
38
40
XCK00
NOMESCO Finland
Perimetry
2.5
18.8
154
648
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
18.8
117
417
N06AX03
ATC
mianserin; oral
2.9
18.7
115
409
ZXD35
NOMESCO Finland
Usual procedure
3.4
18.6
92
280
N05AA02
ATC
levomepromazine; systemic
3.1
18.6
105
351
R50.9
ICD-10 Finland
Fever, unspecified
2.0
18.5
271
1483
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
18.5
73
184
R13
ICD-10 Finland
Dysphagia
2.6
18.4
142
576
I63.8
ICD-10 Finland
Other cerebral infarction
9.2
18.4
38
42
S80.0
ICD-10 Finland
Contusion of knee
2.6
18.2
135
537
G40.10
ICD-10 Finland
Simple partial seizures
8.6
18.2
39
46
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
6.5
18.1
47
74
J46
ICD-10 Finland
Status asthmaticus
3.9
18.0
75
198
R51.81
ICD-10 Finland
Facial pain NOS
4.8
18.0
60
128
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.5
18.0
84
245
R47.1
ICD-10 Finland
Dysarthria and anarthria
8.4
18.0
39
47
M03BX02
ATC
tizanidine; oral
1.5
17.9
1033
8307
J20
ICD-10 Finland
Acute bronchitis
2.2
17.8
184
867
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.7
17.7
77
212
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
9.9
17.6
35
36
R33
ICD-10 Finland
Retention of urine
2.3
17.6
178
831
N05AH03
ATC
olanzapine; systemic
2.8
17.6
119
447
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
4.5
17.6
63
145
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
17.5
133
534
I63
ICD-10 Finland
Cerebral infarction
8.9
17.2
36
41
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.3
17.1
166
762
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
17.6
16.9
26
15
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
8.2
16.8
37
46
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
16.7
251
1385
ZXA05
NOMESCO Finland
Left side
1.7
16.7
451
2998
G83.1
ICD-10 Finland
Monoplegia of lower limb
+∞
16.7
16
*
G83.4
ICD-10 Finland
Cauda equina syndrome
35.4
16.7
21
6
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
8.0
16.6
37
47
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
171.4
16.5
17
*
A01
ICPC
Pain general/multiple sites
2.4
16.5
142
612
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.1
16.4
94
318
G04BD04
ATC
oxybutynin; oral, transdermal
2.5
16.3
129
530
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
7.2
16.3
39
55
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
5.0
16.3
52
106
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
16.3
960
7688
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
4.9
16.2
53
111
A02BC05
ATC
esomeprazole; systemic
1.5
16.2
694
5176
M89.0
ICD-10 Finland
Algoneurodystrophy
9.8
16.2
32
33
XF600
NOMESCO Finland
Bloodpressure measurement
2.4
16.1
137
587
X58
ICD-10 Finland
Exposure to other specified factors
1.9
16.1
239
1312
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
16.1
695
5193
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.3
16.0
83
263
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
16.0
483
3304
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.6
16.0
121
488
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
16.0
190
956
SPAT1254
SPAT
Administration of medicine
1.9
15.9
268
1539
N01
ICPC
Headache
2.1
15.9
178
871
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
3.1
15.8
88
293
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.6
15.8
55
123
N06AB06
ATC
sertraline; oral
2.1
15.8
197
1008
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.2
15.8
42
69
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
15.8
126
523
B01AA03
ATC
warfarin; systemic
1.7
15.8
405
2651
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
15.6
15
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
15.6
145
650
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
15.5
388
2522
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.1
15.4
177
877
R52.0
ICD-10 Finland
Acute pain
3.5
15.4
71
206
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
15.3
193
992
M79.1
ICD-10 Finland
Myalgia
1.9
15.3
223
1216
C08CA01
ATC
amlodipine; oral
1.5
15.2
580
4191
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
13.2
15.2
26
20
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.6
15.2
35
47
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
15.1
125
529
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
6.7
15.1
38
58
D01
ICPC
Abdominal pain/cramps general
2.1
15.1
184
935
R60.0
ICD-10 Finland
Localized oedema
2.0
15.1
210
1124
W19
ICD-10 Finland
Unspecified fall
2.1
15.0
180
907
Z71.8
ICD-10 Finland
Other specified counselling
1.7
14.9
391
2567
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.9
14.9
61
160
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
14.9
120
499
T78.4
ICD-10 Finland
Allergy, unspecified
2.8
14.9
95
345
X57
ICD-10 Finland
Unspecified privation
4.1
14.8
58
146
C10AA01
ATC
simvastatin; oral
1.5
14.8
707
5371
H02AB07
ATC
prednisone; oral
1.8
14.8
279
1660
N05BA12
ATC
alprazolam; oral
2.0
14.8
191
991
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.2
14.7
150
705
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.0
14.7
58
147
M54.3
ICD-10 Finland
Sciatica
2.5
14.7
122
515
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
14.7
315
1951
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.0
14.7
84
285
A04
ICPC
Weakness/tiredness general
1.9
14.6
231
1296
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.7
14.6
49
106
M54.2
ICD-10 Finland
Cervicalgia
2.3
14.6
134
599
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.9
14.6
60
158
WX002
NOMESCO Finland
Sedation and analgesia
1.7
14.5
331
2090
C07AB07
ATC
bisoprolol; oral
1.5
14.5
814
6394
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.0
14.5
46
94
G81
ICD-10 Finland
Hemiplegia
151.1
14.5
15
*
N03AX18
ATC
lacosamide; systemic
9.5
14.4
29
31
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
14.3
592
4353
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
2.8
14.2
92
338
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.0
14.2
84
292
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
14.2
418
2827
G44.0
ICD-10 Finland
Cluster headache syndrome
6.5
14.2
36
56
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.5
14.2
36
56
R07.3
ICD-10 Finland
Other chest pain
2.1
14.1
175
895
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
14.1
219
1217
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
4.3
14.1
52
124
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
14.1
244
1409
R52.9
ICD-10 Finland
Pain, unspecified
2.2
14.1
154
744
J01DA01
ATC
[U] cefalexin; systemic
1.5
14.1
1121
9424
R60.9
ICD-10 Finland
Oedema, unspecified
2.6
14.1
100
390
A02BC03
ATC
lansoprazole; oral
1.5
14.1
512
3651
L12
ICPC
Hand/finger symptom/complaint
1.8
14.0
240
1382
R4130
NOMESCO Finland
Speech therapy
4.0
14.0
56
144
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
14.0
134
608
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.9
14.0
86
306
A02BC01
ATC
omeprazole; systemic
1.6
14.0
494
3498
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.9
13.9
34
50
N02BE01
ATC
paracetamol; systemic, rectal
1.5
13.9
1494
13355
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
13.8
202
1100
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.4
13.8
115
490
XF404
NOMESCO Finland
Ambulatory ECG
2.0
13.8
174
896
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.2
13.7
147
704
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.9
13.7
56
147
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
13.7
13.7
23
17
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
+∞
13.6
13
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
13.6
13
*
J01FA06
ATC
roxithromycin; oral
1.5
13.4
694
5332
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
13.4
469
3310
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
7.1
13.3
32
46
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
11.6
13.3
24
21
F10.25
ICD-10 Finland
Alcohol dependence continuous use
4.6
13.3
45
99
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.9
13.2
219
1247
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.2
13.2
131
606
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
3.0
13.2
75
253
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
13.1
354
2338
ZY010
NOMESCO Finland
Hospital outpatient
2.6
13.0
96
381
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.0
13.0
52
134
M01AE02
ATC
naproxen; oral, rectal
1.4
13.0
944
7745
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
4.7
12.9
43
93
G91.1
ICD-10 Finland
Obstructive hydrocephalus
13.1
12.9
22
17
A02BA02
ATC
ranitidine; systemic
1.6
12.9
361
2404
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
12.9
171
898
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.9
12.8
52
136
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
12.8
91
353
R03AC02
ATC
salbutamol; inhalant
1.4
12.8
877
7104
F61.0
ICD-10 Finland
Mixed personality disorders
4.7
12.8
43
94
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
12.8
94
372
205
Kela drug reimbursment
Chronic hypertension
1.5
12.8
500
3611
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.8
12.7
84
314
K59.1
ICD-10 Finland
Functional diarrhoea
2.5
12.6
100
413
N89
ICPC
Migraine
3.4
12.6
60
180
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
12.6
363
2435
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
12.5
188
1034
G83.2
ICD-10 Finland
Monoplegia of upper limb
130.8
12.4
13
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
12.4
384
2620
N05AX08
ATC
risperidone; systemic
2.0
12.4
155
794
UKC02
NOMESCO Finland
Cystoscopy
1.7
12.4
298
1905
R25.2
ICD-10 Finland
Cramp and spasm
3.8
12.3
52
141
M01AG02
ATC
tolfenamic acid; oral, rectal
1.7
12.3
256
1568
H57.1
ICD-10 Finland
Ocular pain
3.3
12.3
62
194
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
12.3
186
1024
109
Kela drug reimbursment
Multiple sclerosis
5.2
12.3
37
72
S70.0
ICD-10 Finland
Contusion of hip
2.7
12.3
84
320
C01CA24
ATC
epinephrine; parenteral
2.3
12.2
113
508
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.7
12.2
84
321
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.8
12.2
80
297
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.2
12.2
120
555
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
12.2
107
469
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
12.0
441
3132
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.4
12.0
58
176
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
6.3
12.0
31
50
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
12.0
168
900
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.3
12.0
59
182
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
11.9
401
2789
ZX120
NOMESCO Finland
Intravenous
2.0
11.9
166
888
N05CF02
ATC
zolpidem; oral
1.7
11.9
280
1777
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.1
11.9
141
708
C07AA05
ATC
propranolol; systemic
1.6
11.9
314
2057
3AX01
NOMESCO Finland
NA
11.8
11.8
21
18
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
4.1
11.8
45
112
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
11.8
390
2703
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.4
11.8
42
98
H47.2
ICD-10 Finland
Optic atrophy
10.6
11.8
22
21
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
4.1
11.7
44
108
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.5
11.7
53
153
J45
ICD-10 Finland
Asthma
1.9
11.7
166
893
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
11.7
290
1866
C09AA05
ATC
ramipril; oral
1.5
11.7
401
2803
F41.00
ICD-10 Finland
Moderate panic disorder
4.5
11.6
40
90
N05AX12
ATC
aripiprazole; systemic
2.8
11.6
73
266
ZXA00
NOMESCO Finland
Right side
1.5
11.6
453
3261
XF620
NOMESCO Finland
Examination of circulation with color method
11.2
11.5
21
19
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
11.5
176
973
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
2.6
11.4
83
328
G40
ICD-10 Finland
Epilepsy
6.7
11.4
28
42
B01AB05
ATC
enoxaparin; parenteral
1.5
11.4
472
3438
G83.3
ICD-10 Finland
Monoplegia, unspecified
120.7
11.4
12
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
7.5
11.4
26
35
P01AB01
ATC
metronidazole; oral, rectal
1.4
11.4
644
4994
K59.0
ICD-10 Finland
Constipation
2.2
11.4
119
565
RS220
NOMESCO Finland
NA
5.1
11.4
35
70
RS221
NOMESCO Finland
NA
4.3
11.4
41
97
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.7
11.4
79
305
ZX114
NOMESCO Finland
Intramuscular
4.5
11.3
39
88
R74
ICPC
Upper respiratory infection acute
1.5
11.3
419
2980
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
11.3
134
674
EB1WA
NOMESCO Finland
NA
9.7
11.2
22
23
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
11.2
127
624
N86
ICPC
Multiple sclerosis
7.3
11.2
26
36
S22.3
ICD-10 Finland
Fracture of rib
2.2
11.2
116
550
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
11.2
64
218
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.6
11.2
49
138
R47.0
ICD-10 Finland
Dysphasia and aphasia
4.8
11.2
36
76
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.2
11.2
57
181
AA9PW
NOMESCO Finland
NA
25.2
11.1
15
6
R06AE07
ATC
cetirizine; oral
1.4
11.1
688
5422
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.9
11.1
163
888
K92.0
ICD-10 Finland
Haematemesis
3.0
11.1
63
213
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
5.8
11.0
30
52
L86
ICPC
Back syndrome with radiating pain
2.3
11.0
99
439
N29
ICPC
Neurological sympt/complt other
4.0
11.0
43
110
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
4.9
11.0
35
73
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
11.0
73
275
R4150
NOMESCO Finland
Neuropsychological rehabilitation
6.7
11.0
27
41
S89.9
ICD-10 Finland
Unspecified injury of lower leg
2.8
10.9
69
252
R25.1
ICD-10 Finland
Tremor, unspecified
3.0
10.9
60
201
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.8
614
4755
WX110
NOMESCO Finland
Local anesthesy
1.4
10.8
1101
9458
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
10.8
437
3164
SPAT1234
SPAT
Support of social functional capacity
2.3
10.8
98
439
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.2
10.8
108
506
R40.2
ICD-10 Finland
Coma, unspecified
6.2
10.7
28
46
F34.1
ICD-10 Finland
Dysthymia
2.9
10.7
63
220
SPAT1262
SPAT
Handing over of treatment supplies
1.6
10.7
285
1864
G44.8
ICD-10 Finland
Other specified headache syndromes
5.4
10.7
31
58
Z00.0
ICD-10 Finland
General medical examination
1.6
10.7
294
1943
C07AB02
ATC
metoprolol; systemic
1.5
10.7
378
2654
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.6
10.7
47
133
P16
ICPC
Acute alcohol abuse
4.3
10.7
38
89
P03
ICPC
Feeling depressed
2.0
10.7
136
702
W10
ICD-10 Finland
Fall on and from stairs and steps
2.4
10.7
91
393
M79.7
ICD-10 Finland
Fibromyalgia
2.8
10.7
66
237
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
10.6
138
719
G83.8
ICD-10 Finland
Other specified paralytic syndromes
60.3
10.6
12
*
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.7
10.6
45
124
M48.0
ICD-10 Finland
Spinal stenosis
1.8
10.6
200
1186
30180
ICD-8 Finland
Personality disorders, Immatura
11.3
10.5
19
17
N06AA10
ATC
nortriptyline; systemic
3.5
10.5
47
135
L16
ICPC
Ankle symptom/complaint
1.9
10.5
162
900
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
5.4
10.4
30
56
SPAT1240
SPAT
Therapeutic discussion
1.9
10.4
161
895
J01DA06
ATC
[U] cefuroxime; systemic
1.6
10.3
251
1604
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
4.7
10.3
34
74
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
7.1
10.3
24
34
G41.0
ICD-10 Finland
Grand mal status epilepticus
18.9
10.3
15
8
3460A
ICD-9 Finland
Migraine, Classical migraine
18.9
10.3
15
8
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
10.2
69
264
XX3XW
NOMESCO Finland
NA
7.5
10.2
23
31
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.9
10.2
60
211
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
10.1
215
1324
N07BB01
ATC
disulfiram; oral
2.5
10.1
75
303
G50.0
ICD-10 Finland
Trigeminal neuralgia
4.1
10.0
38
95
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
4.4
10.0
35
81
A46
ICD-10 Finland
Erysipelas
1.7
10.0
226
1416
EBA10
NOMESCO Finland
Surgical removal of tooth
1.8
9.9
172
992
UJF32
NOMESCO Finland
Coloscopy
1.5
9.9
405
2931
P29
ICPC
Psychological sympt/compl other
2.4
9.9
86
375
R35
ICD-10 Finland
Polyuria
2.1
9.9
111
545
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.0
9.9
118
596
N05BE01
ATC
buspirone; oral
3.0
9.9
54
181
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
9.9
106
511
C09CA06
ATC
candesartan; oral
1.5
9.9
323
2225
J04.0
ICD-10 Finland
Acute laryngitis
2.9
9.9
59
210
F45.9
ICD-10 Finland
Somatoform disorder, unspecified
12.2
9.8
17
14
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
9.8
280
1865
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.7
9.8
32
69
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.0
9.8
56
191
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
9.8
509
3867
N06AA12
ATC
doxepin; systemic
2.2
9.8
103
493
J01MA12
ATC
levofloxacin; systemic
1.6
9.8
301
2045
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.3
9.7
47
144
KH1AD
NOMESCO Finland
CT of urinary organs
2.9
9.7
58
206
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
9.7
137
738
R2110
NOMESCO Finland
Giving the first information
2.0
9.7
118
598
N05BB01
ATC
hydroxyzine; systemic
2.0
9.7
116
585
Z50.1
ICD-10 Finland
Other physical therapy
2.2
9.7
98
461
SPAT1216
SPAT
Assessment of functional ability
1.6
9.7
258
1688
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
2.2
9.6
95
442
D10
ICPC
Vomiting
2.3
9.6
87
389
M22.4
ICD-10 Finland
Chondromalacia patellae
2.8
9.6
60
218
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
9.6
147
815
P76
ICPC
Depressive disorder
2.2
9.5
94
436
K30
ICD-10 Finland
Functional dyspepsia
1.8
9.5
165
953
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
9.5
156
885
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.1
9.5
51
169
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
9.5
158
902
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
7.2
9.5
22
31
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.3
9.5
34
81
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
4.8
9.5
30
63
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.2
9.5
48
153
A10BA02
ATC
metformin; oral
1.5
9.5
430
3179
P01
ICPC
Feeling anxious/nervous/tense
1.9
9.4
146
812
F32
ICD-10 Finland
Depressive episode
2.4
9.4
80
346
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
9.4
146
813
L03
ICPC
Low back symptom/complaint
1.5
9.4
363
2593
RS222
NOMESCO Finland
NA
4.3
9.4
33
77
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.9
9.4
56
199
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
9.4
287
1945
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
+∞
9.4
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
9.4
502
3827
H46
ICD-10 Finland
Optic neuritis
5.6
9.4
26
47
ZY000
NOMESCO Finland
Hospital inpatient
4.7
9.3
30
64
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
2.5
9.3
71
291
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.1
9.3
50
166
S43.4
ICD-10 Finland
Sprain and strain of shoulder joint
2.6
9.3
64
248
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.9
9.3
145
809
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
9.3
158
909
S18
ICPC
Laceration/cut
1.4
9.3
627
4981
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
2.5
9.3
70
285
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
9.3
161
932
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.6
9.2
40
113
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.4
9.2
32
74
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.7
9.2
38
103
P99
ICPC
Psychological disorders other
2.9
9.2
53
183
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
9.2
169
994
A29
ICPC
General symptom/complaint other
1.7
9.1
179
1076
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
6.7
9.1
22
33
M54.6
ICD-10 Finland
Pain in thoracic spine
2.1
9.1
106
531
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.8
9.1
168
990
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
5.2
9.1
27
53
R03BA02
ATC
budesonide; inhalant
1.6
9.0
279
1894
A03
ICPC
Fever
1.6
9.0
238
1553
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
9.0
63
247
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.0
9.0
120
634
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.8
9.0
36
95
X49
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances
7.1
9.0
21
30
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
7.1
9.0
21
30
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.1
9.0
21
30
L01
ICPC
Neck symptom/complaint
1.7
9.0
202
1260
P06
ICPC
Sleep disturbance
1.8
9.0
146
825
XF402
NOMESCO Finland
ECG with work load test
1.7
9.0
174
1041
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.4
9.0
72
304
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.0
9.0
49
165
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.5
9.0
71
296
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
9.0
187
1145
79199
ICD-8 Finland
Headache
3.6
8.9
38
106
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.2
8.9
87
402
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
8.9
134
738
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
8.9
54
195
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.2
8.9
45
144
N05AF03
ATC
chlorprothixene; systemic
2.9
8.9
52
183
R05
ICPC
Cough
1.5
8.9
324
2286
F45.0
ICD-10 Finland
Somatization disorder
8.0
8.8
19
24
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
5.0
8.8
27
55
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
8.8
297
2057
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
5.2
8.8
26
51
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
3.2
8.8
44
140
R10.0
ICD-10 Finland
Acute abdomen
2.7
8.7
59
224
SPAT1284
SPAT
Extensive health certificate
2.8
8.7
55
203
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
3.3
8.6
41
125
F10.24
ICD-10 Finland
Alcohol depence active use
4.0
8.6
33
84
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
3.7
8.6
36
99
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
3.1
8.6
45
148
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
16.4
8.5
13
8
C10AA07
ATC
rosuvastatin; oral
1.5
8.5
339
2434
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.7
8.5
55
206
J02AC01
ATC
fluconazole; systemic
1.4
8.5
618
4954
WX890
NOMESCO Finland
Intesive care monitoring
5.0
8.5
26
53
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
8.5
181
1114
N17
ICPC
Vertigo/dizziness
1.7
8.5
168
1015
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
3.1
8.4
44
144
S63.5
ICD-10 Finland
Sprain and strain of wrist
2.6
8.4
58
225
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.7
8.4
35
96
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
8.4
150
873
3001A
ICD-9 Finland
Neurotic disorders, Hysteria[KONVERSIOHÄIRIÖ]
90.4
8.4
9
*
C08DA01
ATC
verapamil; systemic
2.2
8.4
84
395
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
8.4
100
506
J01DB01
ATC
cefalexin; oral
1.4
8.4
1376
12486
K10.3
ICD-10 Finland
Alveolitis of jaws
2.3
8.4
73
321
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
3.2
8.4
42
134
G82.5
ICD-10 Finland
Tetraplegia, unspecified
+∞
8.3
8
*
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
+∞
8.3
8
*
L03AB07
ATC
interferon beta-1a; parenteral
6.2
8.3
21
34
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
8.3
78
355
ZXA10
NOMESCO Finland
Bilateral
1.5
8.3
293
2049
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
10.8
8.3
15
14
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.8
8.3
135
767
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.1
8.3
95
474
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
9.5
8.3
16
17
F32.8
ICD-10 Finland
Other depressive episodes
4.4
8.2
28
64
N06AX12
ATC
bupropion; oral
2.1
8.2
94
466
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.2
8.2
40
125
Z72.0
ICD-10 Finland
Tobacco use
3.0
8.2
45
153
XA400
NOMESCO Finland
EEG
6.5
8.2
20
31
N06AX05
ATC
trazodone; oral
2.8
8.2
49
176
G04BD07
ATC
tolterodine; oral
2.1
8.1
94
470
L89
ICD-10 Finland
Decubitus ulcer and pressure area
3.3
8.1
38
115
N06AA06
ATC
trimipramine; systemic
2.8
8.1
49
177
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
8.1
133
754
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.7
8.1
26
56
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
8.1
114
614
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
8.1
361
2649
PA6BM
NOMESCO Finland
MRI examination of neck vasculature with 3 Tesla magnet
33.5
8.1
10
*
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.3
8.1
72
322
N06AG02
ATC
moclobemide; oral
2.2
8.1
77
355
N05AN01
ATC
lithium; oral
2.9
8.0
47
166
A10AA02
ATC
NA
2.4
8.0
68
295
M01AB51
ATC
indometacin, combinations; oral, rectal
2.7
8.0
52
196
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
8.0
55
214
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.9
7.9
113
612
F80.1
ICD-10 Finland
Expressive language disorder
4.9
7.9
24
49
H02AB04
ATC
methylprednisolone; systemic
1.6
7.9
233
1562
N02CC03
ATC
zolmitriptan; nasal, oral
2.1
7.9
85
413
2AB04
NOMESCO Finland
NA
13.1
7.9
13
10
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
13.1
7.9
13
10
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
7.9
116
634
T74.1
ICD-10 Finland
Physical abuse
3.3
7.9
37
113
M35.7
ICD-10 Finland
Hypermobility syndrome
3.9
7.9
30
77
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.7
7.8
50
186
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
4.3
7.8
27
63
J01CA08
ATC
pivmecillinam; oral
1.3
7.8
620
5026
M01AB55
ATC
diclofenac, combinations; oral
1.9
7.8
118
654
R06.4
ICD-10 Finland
Hyperventilation
3.3
7.8
37
114
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.8
7.8
121
676
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.7
7.8
146
867
C08DB01
ATC
diltiazem; oral
1.9
7.8
106
567
D07AA02
ATC
hydrocortisone; topical
1.6
7.7
211
1389
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
7.7
230
1546
S01.0
ICD-10 Finland
Open wound of scalp
1.9
7.7
115
632
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
7.7
121
680
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
7.7
119
665
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
7.7
192
1236
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
3.3
7.7
36
110
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
7.7
210
1385
H66.9
ICD-10 Finland
Otitis media, unspecified
2.0
7.6
88
440
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
7.6
259
1795
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
4.4
7.6
26
60
K92.1
ICD-10 Finland
Melaena
2.0
7.6
94
481
L11
ICPC
Wrist symptom/complaint
1.9
7.6
116
644
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
4.2
7.6
27
65
NA3BM
NOMESCO Finland
Lumbar spine MRI examination with 3 Tesla magnet
8.1
7.6
16
20
R21
ICPC
Throat symptom/complaint
1.5
7.6
275
1935
R03AC03
ATC
terbutaline; inhalant
1.6
7.6
218
1454
N03AX15
ATC
zonisamide; oral
11.9
7.6
13
11
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.7
7.6
49
185
WX730
NOMESCO Finland
Conventional respirator
3.2
7.5
37
117
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
10.1
7.5
14
14
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.3
7.5
26
61
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
2.9
7.5
44
156
N06AB05
ATC
paroxetine; oral
2.0
7.5
96
502
K02.9
ICD-10 Finland
Dental caries, unspecified
3.6
7.5
32
91
SPAT1210
SPAT
Application of cast or individual aid
2.3
7.5
68
308
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
3.3
7.5
35
107
R03AC13
ATC
formoterol; inhalant
2.0
7.4
87
439
N30
ICD-10 Finland
Cystitis
1.8
7.4
120
677
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
3.0
7.4
40
135
N05AD01
ATC
haloperidol; systemic
2.2
7.4
68
309
J01DA08
ATC
[U] cefaclor; oral
1.7
7.4
166
1038
A11
ICPC
Chest pain NOS
1.8
7.4
114
634
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
13.4
7.4
12
9
T90.5
ICD-10 Finland
Sequelae of intracranial injury
4.1
7.4
27
67
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
6.0
7.4
19
32
N05BA02
ATC
chlordiazepoxide; systemic
2.7
7.4
47
174
K04.0
ICD-10 Finland
Pulpitis
1.7
7.4
146
883
R03BB04
ATC
tiotropium bromide; inhalant
1.6
7.4
175
1113
R03AC12
ATC
salmeterol; inhalant
2.0
7.4
90
461
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
7.3
436
3366
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.3
477
3744
3449X
ICD-9 Finland
Other paralytic syndromes, Paralysis, unspecified
+∞
7.3
7
*
N88
ICPC
Epilepsy
6.8
7.3
17
25
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
9.4
7.3
14
15
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
7.3
239
1642
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
7.3
174
1108
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.4
7.3
60
257
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
3.1
7.3
38
126
N05AD03
ATC
melperone; systemic
3.1
7.3
38
126
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
7.2
183
1181
C09AA02
ATC
enalapril; systemic
1.4
7.2
329
2421
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.8
7.2
43
155
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
7.2
95
500
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.1
7.2
80
394
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
7.2
91
473
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
7.2
112
626
G20
ICD-10 Finland
Parkinson disease
2.3
7.2
60
261
L15
ICPC
Knee symptom/complaint
1.5
7.2
290
2087
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
4.4
7.1
24
55
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
20.1
7.1
10
5
R5599
NOMESCO Finland
Other rehabilitation service
2.6
7.1
50
198
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
6.6
7.1
17
26
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.3
7.1
62
274
R05
ICD-10 Finland
Cough
1.5
7.1
281
2010
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
2.9
7.1
41
144
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
4.0
7.1
26
65
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
12.1
7.1
12
10
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
6.0
7.1
18
30
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
6.0
7.1
18
30
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
3.0
7.1
37
123
U04
ICPC
Incontinence urine
2.1
7.1
72
342
S20.2
ICD-10 Finland
Contusion of thorax
2.1
7.0
79
391
S00.0
ICD-10 Finland
Superficial injury of scalp
2.9
7.0
41
145
WX882
NOMESCO Finland
High dependency care
2.5
7.0
50
200
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.1
7.0
13
13
UJD02
NOMESCO Finland
Gastroscopy
2.0
7.0
83
419
J01AA02
ATC
doxycycline; systemic
1.3
7.0
1317
11991
R5110
SPAT
NA
2.7
7.0
46
176
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.0
7.0
37
124
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.5
7.0
30
86
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
3.1
7.0
35
113
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.0
7.0
26
66
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
6.9
789
6710
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
6.9
36
119
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.8
6.9
41
147
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
6.9
93
495
R39.1
ICD-10 Finland
Other difficulties with micturition
2.5
6.9
52
214
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.9
6.9
95
511
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
13.8
6.9
11
8
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
6.9
63
285
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.4
6.8
30
88
K04.08
ICD-10 Finland
Other specified pulpit
1.9
6.8
92
491
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.4
6.8
55
236
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
11.0
6.8
12
11
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
9.3
6.8
13
14
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
9.3
6.8
13
14
N04BC05
ATC
pramipexole; oral
1.8
6.8
113
649
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.8
172
1112
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
2.0
6.8
86
449
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.8
6.8
120
702
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.3
6.8
57
248
RS230
NOMESCO Finland
NA
5.3
6.8
19
36
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.7
6.8
18
32
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.7
844
7260
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.3
6.7
31
94
Y04.2
ICD-10 Finland
Assault by bodily force by friend
16.7
6.7
10
6
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
6.7
57
249
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
6.7
79
399
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.8
6.7
121
709
Z73.6
ICD-10 Finland
Limitation of activities due to disability
4.3
6.7
23
54
N02AC04
ATC
dextropropoxyphene; oral
2.0
6.7
79
400
G40.89
ICD-10 Finland
Other epilepsy
7.2
6.7
15
21
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.2
6.7
32
100
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
4.1
6.7
24
59
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.3
6.7
60
271
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
6.7
429
3352
R32
ICD-10 Finland
Unspecified urinary incontinence
2.5
6.7
48
194
D06
ICPC
Abdominal pain localized other
1.8
6.7
117
681
40199
ICD-8 Finland
Essential benign hypertension
2.6
6.7
45
176
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
6.4
6.6
16
25
M01AH02
ATC
rofecoxib; oral
1.5
6.6
209
1424
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.1
6.6
74
368
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.9
6.6
36
124
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
12.3
6.6
11
9
30041
ICD-8 Finland
Neuroses, Depressiva
3.9
6.6
25
65
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.8
6.6
26
70
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
10.1
6.5
12
12
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
6.9
6.5
15
22
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
6.9
6.5
15
22
X78
ICD-10 Finland
Intentional self-harm by sharp object
6.9
6.5
15
22
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.1
6.5
66
315
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.8
6.5
112
650
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
3.6
6.5
27
76
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
4.0
6.5
24
61
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.0
6.5
34
114
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
6.5
169
1103
Y07
ICD-10 Finland
Other maltreatment
6.2
6.5
16
26
J18
ICD-10 Finland
Pneumonia, organism unspecified
5.3
6.5
18
34
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.0
6.5
81
420
K04.1
ICD-10 Finland
Necrosis of pulp
1.6
6.4
147
926
P74
ICPC
Anxiety disorder/anxiety state
2.3
6.4
53
230
R03DC03
ATC
montelukast; oral
1.5
6.4
231
1621
E66.8
ICD-10 Finland
Other obesity
2.0
6.4
75
380
N85
ICPC
Congenital anomaly neurological
70.1
6.4
7
*
JN4BD
NOMESCO Finland
Extensive body CT
1.6
6.4
159
1022
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.9
6.4
37
130
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
7.4
6.4
14
19
A03FA02
ATC
cisapride; oral, rectal
1.7
6.4
132
810
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.6
6.4
26
72
EBA30
NOMESCO Finland
Excision of root of tooth
2.0
6.4
78
400
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
2.3
6.4
57
256
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
4.9
6.4
19
39
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.6
6.4
42
162
S63.6
ICD-10 Finland
Sprain and strain of finger(s)
2.3
6.3
52
225
G43
ICD-10 Finland
Migraine
2.1
6.3
63
299
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
6.3
92
503
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.8
6.3
37
132
RT150
NOMESCO Finland
NA
8.2
6.3
13
16
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
6.3
336
2540
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.5
6.3
27
78
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.4
6.3
49
207
L01AX03
ATC
temozolomide; systemic
6.0
6.3
16
27
N05CD08
ATC
midazolam; nasal, systemic
2.4
6.3
48
199
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
11.1
6.3
11
10
N81
ICPC
Injury nervous system other
11.1
6.3
11
10
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.7
6.3
41
156
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
6.3
96
537
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
9.3
6.3
12
13
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
9.3
6.3
12
13
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.6
6.3
26
73
M75.5
ICD-10 Finland
Bursitis of shoulder
2.8
6.3
37
133
G56.2
ICD-10 Finland
Lesion of ulnar nerve
2.3
6.3
52
227
XKD00
NOMESCO Finland
Uroflowmetry
1.5
6.3
244
1741
G82.0
ICD-10 Finland
Flaccid paraplegia
+∞
6.3
6
*
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
6.3
6
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.8
6.2
99
559
A10AE04
ATC
insulin glargine; parenteral
1.6
6.2
137
855
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
3.4
6.2
28
84
N73.9
ICD-10 Finland
Female pelvic inflammatory disease, unspecified
3.4
6.2
28
84
G41.8
ICD-10 Finland
Other status epilepticus
26.8
6.2
8
*
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.2
6.2
30
95
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.3
6.2
29
90
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.2
6.2
61
287
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
3.8
6.2
24
64
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
6.3
6.2
15
24
E87.6
ICD-10 Finland
Hypokalaemia
2.4
6.2
50
214
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
6.1
63
300
L02
ICPC
Back symptom/complaint
1.7
6.1
134
832
WX290
NOMESCO Finland
Other blockade of nerve
1.3
6.1
625
5216
L04
ICPC
Chest symptom/complaint
1.9
6.1
83
445
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
7.7
6.1
13
17
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
7.7
6.1
13
17
3459X
ICD-9 Finland
Epilepsy, unspecified
7.7
6.1
13
17
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.9
6.1
83
446
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
3.5
6.1
26
75
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
6.1
103
592
G72.9
ICD-10 Finland
Myopathy, unspecified
4.7
6.1
19
41
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.8
6.1
36
130
I84
ICD-10 Finland
Hemorrhoids
2.4
6.1
48
205
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
3.9
6.1
23
60
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.1
6.1
30
97
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.2
6.0
55
250
Z72.2
ICD-10 Finland
Drug use
6.7
6.0
14
21
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
10.0
6.0
11
11
A08
ICPC
Swelling
2.1
6.0
63
306
JAH01
NOMESCO Finland
Laparoscopy
2.0
6.0
69
345
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
3.5
6.0
26
76
6202X
ICD-9 Finland
Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst
3.5
6.0
26
76
U05
ICPC
Urination problems other
2.0
6.0
67
333
R20.1
ICD-10 Finland
Hypoaesthesia of skin
5.2
6.0
17
33
G51.0
ICD-10 Finland
Bell palsy
2.4
6.0
46
191
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
605
2342
3.23
117.31
3.6
2.0
s
29.7
29.8
0.17
584
2266
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
910
4580
2.75
107.35
3.2
2.1
u/l
156.9
221.6
1.87
878
4302
(3044290) Cell count panel - Cerebral spinal fluid
163
289
6.03
88.78
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
175
361
5.20
80.75
1.6
1.3
mg/l
463.7
497.0
0.59
164
338
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
160
322
5.30
75.86
1.6
1.5
e6/l
300.0
695.5
0.45
126
263
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
160
322
5.30
75.86
1.6
1.4
e6/l
6.6
37.4
0.98
120
253
(3033658) Prothrombin time (PT) actual/Normal
731
3896
2.35
69.60
6.1
3.8
%
91.2
89.6
0.87
720
3788
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
153
322
5.05
68.82
1.4
1.3
mmol/l
3.7
3.8
0.09
140
299
(3023410) Appearance of Cerebral spinal fluid
101
148
7.12
65.99
1.4
1.6
—
—
—
0
0
(3036489) Thrombin time
199
581
3.68
58.05
3.0
1.9
s
20.8
21.4
1.16
182
519
(3030467) Casts [#/volume] in Urine by Automated count
735
4289
2.10
52.92
4.0
3.2
e6/l
0.4
0.5
0.94
580
3272
(36304419) Bacteria [Presence] in Urine
722
4196
2.10
52.45
4.0
3.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
74
100
7.63
51.89
1.1
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
557
2953
2.21
51.06
5.2
3.8
ng/l
139.8
360.5
2.41
413
2292
(3032080) INR in Blood by Coagulation assay
965
6288
1.99
50.56
10.6
9.6
inr
1.2
1.3
1.11
249
1825
(3002582) Erythrocytes [#/volume] in Urine
780
4714
2.05
50.55
4.2
3.3
e6/l
114.5
85.6
0.16
625
3650
(3013826) Glucose [Moles/volume] in Serum or Plasma
1262
9095
1.98
48.56
6.8
4.7
mmol/l
6.5
6.7
2.13
1217
8506
(3023368) Bacteria identified in Blood by Culture
724
4326
2.03
47.87
5.1
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
478
2461
2.22
46.58
3.6
3.0
e6/l
3.3
2.4
1.01
265
1361
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
85
152
5.79
45.64
1.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
563
3113
2.11
45.59
3.1
2.8
mosm/kgh2o
545.2
546.9
0.07
499
2637
(3016018) Differential panel - Cerebral spinal fluid
83
146
5.88
45.33
1.5
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
856
5504
1.94
45.17
5.1
3.8
e6/l
56.3
107.8
1.96
642
3924
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
597
3401
2.06
44.44
2.6
1.7
mg/l
0.9
1.2
3.71
459
2584
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
71
109
6.71
44.35
1.3
1.2
mg/l
32.8
37.3
0.49
60
89
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
77
130
6.11
43.85
1.0
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
319
1419
2.47
43.36
3.0
2.4
u/l
30.2
41.2
1.90
279
1208
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1010
6988
1.86
41.42
7.6
6.0
mmol/l
1.2
1.2
1.08
935
6314
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
482
2611
2.10
40.60
3.5
2.8
e6/l
1.1
1.2
0.26
266
1506
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
66
106
6.40
39.48
1.2
1.1
mg/l
237.9
244.1
0.13
58
91
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
74
136
5.60
38.59
2.1
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
960
6646
1.82
38.31
5.1
4.8
g/l
35.1
35.4
0.84
882
6181
(3014111) Lactate [Moles/volume] in Serum or Plasma
298
1359
2.39
38.06
8.0
7.2
mmol/l
1.3
1.4
0.50
285
1304
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1070
7711
1.80
36.83
7.9
6.6
mmol/l
1.2
1.2
0.50
922
6472
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
466
2591
2.03
36.07
2.0
1.8
—
—
—
0
0
(4027681)
58
91
6.53
35.48
1.4
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
451
2495
2.03
35.32
4.5
3.3
mmol/l
0.8
0.8
2.72
414
2331
(42870588) Differential panel, method unspecified - Blood
780
5231
1.78
33.32
6.8
5.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
698
4537
1.81
33.08
4.2
3.9
ph
7.4
7.4
0.19
125
855
(3026008) Bacteria identified in Urine by Culture
716
4697
1.80
32.86
4.0
3.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1091
8074
1.74
32.75
6.2
6.0
umol/l
10.5
11.6
2.06
1036
7630
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
51
76
6.85
32.74
1.1
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
548
3319
1.88
32.53
3.1
2.6
e6/l
6.6
5.9
0.51
491
2917
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
348
1805
2.11
32.18
1.9
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
738
4929
1.77
31.58
2.8
2.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
277
1322
2.26
31.53
10.5
8.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1313
10299
1.74
31.36
6.6
4.5
e6/l
654.8
1949.7
0.89
15
156
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
47
70
6.84
30.19
1.3
1.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1041
7713
1.70
30.18
7.4
5.7
e9/l
0.6
0.6
0.01
907
6668
(3006315) Basophils [#/volume] in Blood
1041
7738
1.69
29.61
7.4
5.7
e9/l
0.0
0.0
0.13
904
6696
(4198724)
39
48
8.26
29.52
1.9
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
341
1810
2.06
29.46
1.9
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
294
1480
2.15
29.20
4.9
3.8
kpa
5.9
5.8
0.05
283
1425
(3013115) Eosinophils [#/volume] in Blood
1065
8015
1.67
28.48
7.8
5.9
e9/l
0.2
0.2
0.78
937
7043
(3002032) Base excess in Venous blood by calculation
290
1470
2.13
28.25
4.9
3.8
mmol/l
2.0
1.9
0.03
240
1148
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
186
782
2.51
28.07
5.2
4.2
mmol/l
24.2
24.0
0.57
174
712
(3019069) Monocytes/100 leukocytes in Blood
988
7312
1.67
28.03
7.8
6.1
%
8.3
8.6
2.19
934
6846
(3019198) Lymphocytes [#/volume] in Blood
1054
7932
1.66
28.02
7.6
5.7
e9/l
2.0
1.9
0.09
931
7001
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
112
359
3.24
28.00
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
112
359
3.24
28.00
1.4
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
30
28
10.85
27.80
1.2
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
204
906
2.39
27.31
1.3
1.3
au/ml
57.5
42.2
—
7
41
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
873
6297
1.66
27.07
2.3
2.0
pmol/l
90.8
94.5
1.58
476
3289
(3006504) Eosinophils/100 leukocytes in Blood
980
7281
1.65
27.06
7.5
5.8
%
2.6
2.8
3.08
921
6779
(3002030) Lymphocytes/100 leukocytes in Blood
1005
7520
1.65
26.94
7.7
5.9
%
27.5
27.8
0.40
945
7011
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
207
935
2.35
26.65
1.9
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
348
1927
1.97
26.49
8.3
6.9
mmol/l
104.7
104.3
0.82
343
1886
(3022096) Basophils/100 leukocytes in Blood
953
7070
1.64
26.17
7.6
5.9
%
0.6
0.7
1.18
893
6586
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
188
821
2.42
26.10
10.5
9.8
mmol/l
24.7
24.3
0.83
176
767
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
42
65
6.57
26.03
3.5
2.2
umol/l
66.9
48.3
2.23
34
51
(3018010) Neutrophils/100 leukocytes in Blood
988
7403
1.64
26.02
7.5
5.7
%
57.8
57.4
0.62
932
6927
(3003458) Phosphate [Moles/volume] in Serum or Plasma
367
2081
1.93
26.01
6.3
5.8
mmol/l
1.0
1.0
0.04
339
1923
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
322
1761
1.98
25.33
2.7
2.7
umol/l
7.3
8.4
0.45
279
1531
(3037467) Urinalysis macro (dipstick) panel - Urine
1325
10722
1.65
25.23
5.9
4.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
81
5.78
25.10
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
132
498
2.76
24.74
3.4
3.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
48
90
5.43
24.51
1.1
1.1
u/l
1.0
1.1
0.70
19
45
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
826
5987
1.63
24.40
5.1
3.6
ng/l
106.0
52.7
0.32
557
4073
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
120
437
2.85
24.03
2.4
2.3
%
179.3
180.1
0.03
114
418
(3013650) Neutrophils [#/volume] in Blood by Automated count
1145
9000
1.60
24.01
10.1
8.7
e9/l
4.4
4.1
2.47
996
7868
(40758558) Short blood count panel - Blood
592
3959
1.69
23.85
7.4
6.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
233
1157
2.14
23.76
1.8
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
318
1773
1.94
23.53
8.9
7.6
kpa
5.1
5.1
0.05
301
1682
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
135
529
2.66
23.49
2.2
2.3
ug/l
241.6
471.6
1.26
127
493
(3003396) Base excess in Arterial blood by calculation
316
1766
1.93
23.20
9.0
7.6
mmol/l
1.1
1.2
0.07
257
1358
(3027801) Oxygen [Partial pressure] in Arterial blood
317
1774
1.93
23.18
8.9
7.6
kpa
12.2
12.0
0.28
302
1685
(3024354) Oxygen [Partial pressure] in Venous blood
242
1234
2.09
23.00
4.4
3.1
kpa
4.9
4.6
1.01
232
1186
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
36
56
6.52
22.20
3.4
2.7
umol/l
30.0
30.7
0.11
26
41
(3019309) Folate [Moles/volume] in Red Blood Cells
460
2951
1.72
21.26
1.9
1.8
nmol/l
1050.1
1194.1
2.75
354
2216
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
556
3755
1.66
21.15
2.8
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
257
1382
1.98
21.02
6.7
7.7
mmol/l
9.4
10.1
0.77
239
1313
(3028707) Methadone [Presence] in Urine by Screen method
73
216
3.47
20.75
5.1
2.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
262
1430
1.95
20.50
2.3
2.1
nmol/l
378.3
369.1
0.29
237
1305
(4268621)
59
156
3.86
19.78
2.2
2.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
673
4839
1.58
19.48
3.0
2.5
u/l
56.7
57.3
0.12
622
4475
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
695
5045
1.57
19.24
3.7
3.2
u/l
29.5
32.9
2.62
651
4802
(3005719) IgG [Mass/volume] in Serum or Plasma
212
1101
2.03
19.07
2.4
2.7
g/l
10.0
10.6
1.30
186
1009
(3011397) Hemoglobin [Presence] in Urine by Test strip
515
3516
1.62
18.37
4.5
3.6
—
—
—
0
0
(3015736) pH of Urine
780
5871
1.52
18.04
4.5
3.4
—
5.6
—
0
5
(3022217) INR in Platelet poor plasma by Coagulation assay
336
2061
1.75
17.96
27.2
26.6
inr
1.5
1.4
0.69
36
271
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
436
2872
1.65
17.89
2.9
3.0
mmol/l
2.4
2.5
0.20
359
2521
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
117
490
2.47
17.75
8.4
2.0
%
92.9
90.5
0.45
109
457
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
299
1782
1.79
17.62
2.0
1.8
%
1.6
1.5
1.70
257
1555
(3015377) Calcium [Moles/volume] in Serum or Plasma
711
5269
1.53
17.57
3.3
3.3
mmol/l
2.3
2.4
1.27
600
4625
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1405
11991
1.53
17.43
9.0
7.3
u/l
81.6
79.1
0.98
1318
11237
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
109
449
2.51
17.14
5.8
2.3
g/l
3.8
3.6
0.43
102
420
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
72
239
3.08
17.03
1.3
1.2
u/ml
1.3
3.8
1.28
20
72
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
573
4095
1.55
16.52
2.6
2.2
mg/l
3.1
3.0
0.63
494
3463
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
70
236
3.03
16.14
1.3
1.2
u/ml
3.0
4.4
0.60
30
97
(3014007) Fractional oxyhemoglobin in Arterial blood
183
960
1.99
15.95
12.0
9.4
%
94.0
93.6
0.43
183
955
(3021589) Normoblasts [#/volume] in Blood
874
6858
1.47
15.91
12.3
9.3
e9/l
0.0
0.0
0.11
701
5601
(3021960) Folate [Moles/volume] in Serum or Plasma
513
3607
1.56
15.80
1.7
1.6
nmol/l
19.0
20.5
1.28
445
3097
(3042936) Bacteria identified in Isolate by Culture
350
2260
1.66
15.31
2.5
2.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1340
11467
1.47
15.24
5.1
4.0
mm/h
13.5
12.4
1.64
1246
10583
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
30
57
5.32
15.14
6.5
3.6
umol/l
133.8
130.6
0.03
15
36
(3037522) Nuclear Ab [Titer] in Serum
319
2032
1.67
14.66
1.5
1.3
titre
471.7
505.1
0.11
53
422
(3020630) Protein [Mass/volume] in Serum or Plasma
218
1249
1.83
14.54
1.7
2.6
g/l
65.7
66.7
0.94
187
1136
(3007853) Bacteria identified in Skin by Aerobe culture
290
1814
1.69
14.25
2.2
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
40
6.06
13.86
1.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
810
6415
1.43
13.34
2.5
2.2
nmol/l
74.8
76.9
1.15
735
5745
(3035350) Ketones [Presence] in Urine by Test strip
932
7572
1.42
13.28
5.0
3.6
estimate
0.0
0.0
0.00
176
1422
(3009466) Valproate [Moles/volume] in Serum or Plasma
66
241
2.79
13.23
5.2
5.6
umol/l
356.4
358.7
0.04
57
214
(3022948) Iron [Moles/volume] in Serum or Plasma
366
2470
1.58
13.22
2.8
2.5
umol/l
11.6
13.0
2.55
340
2276
(3024928) Oxygen saturation in Venous blood
82
335
2.51
13.17
2.4
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
320
2099
1.62
13.01
3.0
2.6
%
20.5
22.9
1.93
279
1810
(3002173) Hemoglobin [Mass/volume] in Arterial blood
236
1430
1.73
12.98
10.9
8.6
g/l
123.9
121.1
1.35
229
1376
(3051651) Icteric interference index of Serum or Plasma
38
100
3.85
12.90
2.9
3.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
930
7582
1.41
12.84
6.9
4.9
estimate
0.0
0.0
0.50
178
1448
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
82
340
2.47
12.77
2.5
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
18
24
7.55
12.70
1.3
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
82
342
2.45
12.61
2.5
3.1
umol/l
31.7
35.4
1.03
71
288
(3016502) Oxygen saturation in Arterial blood
252
1575
1.68
12.35
10.7
8.1
%
96.0
95.4
0.92
245
1513
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
33
81
4.12
12.31
13.8
12.5
mmol/l
0.6
0.7
1.01
28
73
(3009261) Glucose [Presence] in Urine by Test strip
935
7668
1.40
12.29
5.1
3.6
estimate
0.0
0.0
0.34
175
1395
(3004789) Transferrin [Mass/volume] in Serum or Plasma
337
2272
1.58
12.16
2.8
2.5
g/l
2.3
2.3
0.10
304
2096
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
38
105
3.67
12.05
1.0
1.1
nmol/l
0.1
4.0
—
9
20
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
587
4450
1.44
11.99
3.4
3.0
ng/l
1301.0
1725.8
1.58
503
3784
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
176
1003
1.82
11.91
4.9
3.9
mmol/l
1.7
1.7
0.04
133
734
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
26
54
4.86
11.90
1.2
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
181
1043
1.80
11.81
4.9
3.9
ph
7.4
7.4
0.39
24
117
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
147
793
1.92
11.81
13.6
11.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
100
469
2.19
11.75
1.3
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
182
1054
1.80
11.68
5.0
3.9
kpa
5.2
5.1
0.25
169
980
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
40
5.55
11.64
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
49
164
3.03
11.52
2.9
3.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
41
5.41
11.35
1.0
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
231
1444
1.67
11.29
2.6
2.3
g/l
0.2
0.2
1.38
212
1343
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
215
1321
1.70
11.21
2.3
2.4
ug/l
6.4
6.8
0.13
179
1154
(40768797) Stomach Pathology biopsy report
313
2123
1.56
10.93
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
105
521
2.07
10.70
10.0
2.6
u/ml
0.3
0.4
0.34
56
292
(3001122) Ferritin [Mass/volume] in Serum or Plasma
845
6924
1.37
10.68
3.4
2.8
ug/l
117.5
126.0
0.48
777
6399
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
71
300
2.41
10.66
1.7
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
880
7267
1.36
10.55
4.7
4.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
20
37
5.45
10.40
1.1
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
14
18
7.82
10.14
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
161
938
1.78
10.13
1.5
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
20
38
5.30
10.11
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
28
71
3.98
10.04
3.3
15.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
258
1707
1.58
10.00
3.6
4.1
u/l
235.2
243.6
0.53
243
1615
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
57
225
2.58
9.90
1.1
1.1
%
122.7
117.9
0.55
52
208
(3027945) Reticulocytes/100 erythrocytes in Blood
267
1785
1.57
9.90
2.6
2.7
%
1.8
1.8
0.25
232
1593
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
14
19
7.41
9.70
1.0
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
130
723
1.85
9.54
2.8
2.7
%
1.6
1.2
2.96
130
718
(1001926) Buprenorphine [Presence] in Urine by Screen method
83
395
2.15
9.46
4.9
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
90
442
2.08
9.46
1.5
1.5
ug/g
282.3
288.2
0.10
57
256
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
33
98
3.40
9.45
1.5
2.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
80
376
2.17
9.41
1.5
1.3
—
10.5
—
0
7
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
94
474
2.03
9.21
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
92
461
2.04
9.17
1.6
2.2
g/l
38.0
37.7
0.16
77
398
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
85
414
2.10
9.14
1.6
2.3
g/l
0.0
0.0
0.00
76
380
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
16
27
5.96
9.12
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
89
443
2.05
9.04
1.6
2.3
g/l
0.1
0.0
0.37
80
405
(4306422)
57
236
2.45
8.99
1.2
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
359
2605
1.46
8.95
1.4
1.3
iu/ml
30.2
32.3
0.07
91
828
(3007164) IgA [Mass/volume] in Serum or Plasma
399
2954
1.43
8.94
1.6
1.4
g/l
2.2
2.4
1.28
229
1784
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
85
418
2.08
8.92
1.6
2.3
g/l
0.0
0.0
0.00
76
381
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
51
4.35
8.87
1.3
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
21
47
4.50
8.83
1.1
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
73
341
2.18
8.74
2.8
2.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
540
1.93
8.72
1.5
2.3
g/l
10.1
10.5
0.40
84
461
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
95
492
1.97
8.65
1.6
2.4
g/l
0.3
1.1
2.83
79
430
(3016879) Cocaine [Presence] in Urine
93
479
1.99
8.61
4.5
1.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
48
188
2.59
8.51
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
446
3405
1.39
8.33
1.3
1.3
u/ml
2.9
1.6
0.62
91
903
(4010399)
169
1058
1.65
8.21
1.4
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
56
241
2.36
8.15
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
17
34
5.03
8.14
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
165
1029
1.65
8.13
1.5
2.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
29
88
3.33
8.07
1.2
1.6
u/l
4.7
6.5
1.18
21
72
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
393
2.05
8.06
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
96
513
1.91
8.00
4.5
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
96
520
1.89
7.69
4.5
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
579
1.84
7.65
1.5
2.2
g/l
7.0
7.3
1.03
79
447
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
152
944
1.66
7.62
3.4
3.3
pmol/l
4.3
4.5
2.71
137
832
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
12
18
6.70
7.60
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
95
518
1.87
7.47
4.4
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
195
1294
1.56
7.44
2.6
2.7
e9/l
70.9
70.8
0.01
136
974
(3027944) Amphetamines [Presence] in Urine
94
512
1.87
7.42
4.7
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
578
1.82
7.40
1.5
2.2
g/l
3.9
3.7
0.32
79
426
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
579
1.82
7.36
1.5
2.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
509
4043
1.34
7.29
2.7
2.6
umol/l
3203.3
5939.5
1.02
421
3495
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
232
1606
1.50
7.29
4.5
3.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
29
95
3.08
7.16
1.0
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
77
1409
0.53
7.12
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
549
1.82
7.09
1.6
2.3
g/l
2.9
3.1
1.35
79
435
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
177
1170
1.56
6.88
3.5
4.0
ng/l
85.1
89.0
0.25
146
1028
(3048689) Calprotectin [Mass/mass] in Stool
258
1845
1.45
6.88
2.2
2.4
ug/g
116.1
124.6
0.22
190
1457
(3017143) Hepatitis C virus Ab [Presence] in Serum
239
1684
1.47
6.87
1.5
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
62
301
2.09
6.80
2.6
2.6
%
16.6
16.2
0.27
32
163
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
113
669
1.73
6.79
5.5
4.2
mmol/l
24.8
24.7
0.05
104
626
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1144
10187
1.27
6.70
4.3
3.1
u/l
54.9
48.9
1.28
1065
9510
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
14
7.17
6.70
1.1
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
139
875
1.63
6.64
2.0
1.8
g/l
1.3
1.5
0.40
129
806
(44816559) Phosphatidylethanol [Mass/volume] in Blood
58
278
2.12
6.59
1.4
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
440
5483
0.75
6.58
3.1
2.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
126
776
1.66
6.56
5.4
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
83
454
1.86
6.50
2.4
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
108
640
1.72
6.48
2.0
1.9
ug/l
2.8
1.6
0.45
90
561
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1315
11937
1.27
6.45
4.7
4.0
pmol/l
14.6
14.7
1.47
1202
10871
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
331
2507
1.38
6.36
1.3
1.2
u/ml
4.6
11.1
2.15
109
989
(3023511) Choriogonadotropin [Units/volume] in Urine
56
269
2.11
6.34
1.6
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
86
482
1.82
6.25
2.6
2.1
u/l
6670.0
3928.8
0.31
24
200
(3035637) Corticotropin [Mass/volume] in Plasma
40
168
2.41
6.21
1.7
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
24
77
3.14
6.16
2.3
2.6
u/ml
993.5
1392.4
0.33
24
77
(36660697) Celiac disease serology panel - Serum
176
1196
1.51
6.05
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
78
429
1.85
6.03
1.3
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
59
299
2.00
5.82
1.5
1.2
u/ml
38.9
50.0
—
7
24
(3021387) Prolactin [Units/volume] in Serum or Plasma
90
524
1.75
5.78
1.6
1.6
mu/l
400.6
303.5
0.96
77
481
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
31
120
2.61
5.72
1.2
1.1
titre
170.0
149.5
—
5
19
(3024980) IgG subclass 4 [Mass/volume] in Serum
48
227
2.14
5.68
1.5
1.6
g/l
0.7
0.8
0.46
38
169
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
51
3.55
5.60
1.1
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
73
403
1.84
5.60
1.9
1.4
u/l
11.4
10.7
0.17
52
320
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
29
4.50
5.51
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
78
2.97
5.41
1.7
1.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
29
112
2.61
5.39
2.2
1.5
promille
1.7
1.3
0.78
21
89
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
184
1293
1.46
5.38
3.2
2.9
ng/l
228.0
220.2
0.08
158
1175
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
18
5.58
5.32
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
18
5.58
5.32
1.1
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
23
79
2.93
5.30
1.2
1.3
nmol/l
146.0
144.1
0.05
23
79
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
81
471
1.75
5.25
1.5
1.6
iu/ml
0.1
14.0
0.49
22
86
(3021788) Differential panel - Synovial fluid
54
276
1.98
5.23
1.7
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
72
406
1.80
5.18
1.6
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
38
172
2.23
5.04
1.4
1.4
mu/l
112.5
44.9
0.48
30
154
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
19
5.28
5.04
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
79
464
1.73
4.97
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
82
489
1.70
4.89
1.6
1.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
72
414
1.77
4.88
5.0
3.3
mmol/l
24.8
24.8
0.00
64
366
(3023323) Follitropin [Units/volume] in Serum or Plasma
113
732
1.57
4.86
1.6
1.4
iu/l
22.0
28.8
1.52
89
618
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
89
2.72
4.84
2.3
2.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
239
1797
1.37
4.79
1.6
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
79
470
1.71
4.76
1.5
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
12
29
4.16
4.62
1.2
1.1
%
106.8
92.3
1.39
12
29
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
207
1534
1.39
4.53
2.7
4.0
ug/l
27.0
18.6
0.21
152
1256
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
8
10.03
4.52
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
278
2160
1.33
4.50
1.5
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
38
181
2.12
4.48
1.6
1.3
mosm/kgh2o
281.8
279.0
0.34
27
133
(3012501) Base excess in Blood by calculation
61
343
1.80
4.48
5.0
4.6
mmol/l
2.3
2.6
0.55
44
233
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
49
3.28
4.46
1.1
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
77
464
1.68
4.45
1.3
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
100
645
1.58
4.41
1.5
2.0
u/l
41.5
39.3
0.49
88
575
(3003181) Sodium [Moles/volume] in Urine
51
273
1.89
4.37
1.7
1.3
mmol/l
68.0
63.5
0.27
40
217
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
64
368
1.76
4.37
1.5
1.2
u/ml
3.4
10.0
—
5
59
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
151
1066
1.45
4.35
1.1
1.2
iu/ml
206.9
150.2
0.53
46
420
(46235355) HIV 1 and 2 tests - Meaningful Use set
325
2593
1.30
4.34
1.7
1.8
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
59
332
1.80
4.33
2.1
2.2
g/l
130.7
129.8
0.10
41
249
(3019060) Gas panel - Arterial blood
147
1035
1.45
4.30
5.6
5.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
486
4087
1.25
4.21
6.0
3.9
estimate
0.0
0.0
1.08
169
1385
(1616796) Gas panel - Central venous blood
61
351
1.76
4.17
4.1
3.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
106
703
1.53
4.16
1.8
1.9
g/l
1.5
1.5
0.15
89
616
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
14
6.45
3.98
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
93
2.49
3.96
1.4
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
49
853
0.56
3.91
1.6
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
24
100
2.42
3.89
2.1
2.1
%
13.5
14.6
0.13
14
48
(3024139) IgG subclass 3 [Mass/volume] in Serum
29
132
2.21
3.86
1.3
1.3
g/l
0.3
0.4
0.54
23
88
(3027135) IgG subclass 1 [Mass/volume] in Serum
29
132
2.21
3.86
1.3
1.3
g/l
6.9
7.0
0.04
23
90
(3028192) IgG subclass 2 [Mass/volume] in Serum
29
132
2.21
3.86
1.3
1.3
g/l
2.7
2.9
0.13
23
88
(3005322) IgE [Units/volume] in Serum or Plasma
138
983
1.43
3.82
1.2
1.2
u/ml
130.6
194.8
0.90
127
906
(3021879) Hepatitis B virus core Ab [Presence] in Serum
151
1094
1.41
3.81
1.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
27
120
2.27
3.80
2.7
3.5
%
10.7
11.0
0.12
27
120
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
174
2.03
3.74
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
94
623
1.53
3.73
5.5
4.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
90
591
1.55
3.72
2.3
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
44
238
1.87
3.70
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
31
148
2.11
3.69
1.2
1.2
u/l
52.5
57.6
0.18
20
106
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
97
649
1.52
3.69
2.3
1.9
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
61
365
1.69
3.67
1.6
1.7
e6/l
8936.4
13105.4
0.66
43
274
(40768443) Skin Pathology biopsy report
97
650
1.52
3.66
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
9
16
5.64
3.65
3.0
2.0
—
—
—
0
0
(4062490)
29
136
2.15
3.61
1.3
1.3
—
—
—
0
0
(3010421) pH of Blood
68
421
1.64
3.60
4.7
4.2
ph
7.4
7.4
0.10
61
338
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
94
631
1.51
3.53
1.0
1.1
—
0.9
—
0
9
(3028717) Thiamine [Mass/volume] in Blood
8
13
6.17
3.50
1.1
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
94
1366
0.67
3.50
1.8
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
33
165
2.02
3.50
8.6
7.6
mmol/l
6.7
7.3
0.76
28
145
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
204
1574
1.33
3.48
2.1
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
28
132
2.14
3.45
2.0
2.2
e9/l
1.5
1.1
0.99
15
75
(3009508) Creatinine [Moles/volume] in Urine
535
4629
1.21
3.45
3.7
3.1
mmol/l
7.6
7.5
0.06
438
3897
(3019150) Specific gravity of Urine by Refractometry
396
3326
1.23
3.42
5.7
4.0
kg/l
1.0
1.0
0.02
60
470
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
61
373
1.65
3.41
1.2
1.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
100
686
1.48
3.40
5.4
3.7
%
51.3
48.0
0.71
100
676
(3044941) Cell count panel - Synovial fluid
43
238
1.82
3.40
1.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
50
290
1.74
3.38
4.0
2.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
185
1415
1.34
3.36
2.0
1.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
10
27
3.72
3.35
1.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1636
15627
1.22
3.34
25.8
14.3
mg/l
23.0
24.2
0.86
1441
12390
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
79
519
1.54
3.29
2.8
2.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
73
471
1.57
3.29
6.9
7.0
mmol/l
1.3
1.3
0.05
58
405
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
7
8.59
3.26
1.0
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
700
6241
1.18
3.20
2.1
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
28
3.58
3.19
1.6
3.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
66
420
1.59
3.17
1.5
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1674
17352
0.82
3.16
35.4
20.9
g/l
132.5
134.5
6.55
1653
17058
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
20
85
2.37
3.15
1.3
1.2
u/l
26.8
17.4
0.53
13
73
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
172
1.93
3.14
1.9
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
1674
17346
0.82
3.10
35.1
20.8
e12/l
4.4
4.5
3.09
1637
16832
(3016650) Hepatitis A virus Ab [Presence] in Serum
42
238
1.78
3.10
1.1
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
1674
17345
0.82
3.09
34.9
20.7
pg
30.2
30.3
0.71
1653
17046
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
50
2.81
3.08
1.1
1.1
—
—
—
0
0
(3024731) MCV [Entitic volume]
1674
17343
0.82
3.08
35.0
20.8
fl
91.0
91.0
0.01
1653
17049
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
20
86
2.34
3.08
1.3
1.2
u/l
118.4
79.7
0.94
15
75
(3010813) Leukocytes [#/volume] in Blood
1675
17351
0.82
3.06
35.1
20.9
e9/l
7.1
6.8
3.73
1638
16832
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
22
99
2.23
3.06
1.6
2.3
e6/l
578.3
555.5
0.07
16
86
(3000060) B lymphocytes [#/volume] in Blood
11
34
3.25
3.05
2.1
2.2
e6/l
203.3
204.3
—
6
14
(1002224) Polysomnography panel
91
627
1.47
3.05
1.1
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1432
15034
0.85
3.02
4.9
4.2
mmol/l
1.4
1.5
9.18
1314
13826
(3007461) Platelets [#/volume] in Blood
1674
17336
0.82
3.01
35.1
20.8
e9/l
256.6
251.3
2.49
1638
16864
(3013512) EKG study
505
4401
1.19
2.97
5.0
3.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
95
2.22
2.90
1.7
2.3
e9/l
0.4
0.2
0.44
16
85
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1446
15144
0.85
2.84
5.0
4.3
mmol/l
4.5
4.7
9.58
1332
14032
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
77
2.35
2.82
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
108
784
1.40
2.76
2.5
2.4
—
—
—
0
0
(4094501)
59
379
1.57
2.76
1.2
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
41
241
1.71
2.71
1.2
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
34
189
1.81
2.71
1.4
1.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
182
1.83
2.69
1.9
1.6
%
40.2
60.8
1.62
18
116
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
19
4.22
2.67
1.3
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
127
953
1.35
2.67
8.8
7.1
mmol/l
24.5
24.5
0.03
118
889
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1479
15438
0.85
2.67
5.5
4.7
mmol/l
2.6
2.8
7.74
1357
14200
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
30
161
1.88
2.66
1.3
1.4
pmol/l
291.0
307.4
0.15
24
122
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
81
564
1.45
2.62
1.7
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
68
458
1.50
2.59
2.2
1.9
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
34
192
1.78
2.58
1.4
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
130
985
1.34
2.57
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
1153
10804
1.15
2.57
4.3
3.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
8
20
4.01
2.56
3.9
1.5
mmol/l
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
20
94
2.14
2.54
3.0
2.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
515
4556
1.17
2.51
4.1
3.9
mg/mmol
10.0
9.0
0.18
331
2911
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
159
1245
1.30
2.50
4.8
3.7
mmol/l
1.2
1.2
0.47
146
1069
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
650
5861
1.16
2.47
5.8
3.8
—
—
—
0
0
(4024509)
25
130
1.93
2.45
1.4
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1489
14237
1.16
2.42
5.9
4.7
mu/l
2.6
2.1
0.25
1375
13026
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
63
914
0.68
2.40
1.6
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
32
182
1.77
2.40
1.2
1.3
nmol/l
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
33
190
1.75
2.37
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
33
190
1.75
2.37
1.4
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
22
3.65
2.36
3.5
2.7
u/field
0.8
0.7
—
8
22
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
39
236
1.66
2.36
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
52
2.51
2.36
1.5
2.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
33
191
1.74
2.34
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
33
191
1.74
2.34
1.4
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
147
1.85
2.33
3.4
4.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
32
184
1.75
2.32
1.4
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
269
1.61
2.29
3.4
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
450
3969
1.17
2.26
1.7
1.6
mmol/l
1.5
1.4
1.03
386
3353
(40759836) Histone Ab [Presence] in Serum by Immunoblot
21
106
1.99
2.25
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
21
106
1.99
2.25
1.4
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
21
106
1.99
2.25
1.4
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
258
0.42
2.24
1.4
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
93
2.05
2.21
1.7
1.6
u/l
6.5
8.7
—
10
48
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
107
1.97
2.20
1.5
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
21
107
1.97
2.20
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
21
107
1.97
2.20
1.5
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
158
1.78
2.17
1.7
3.3
%
61.8
55.3
0.75
18
110
(3019550) Sodium [Moles/volume] in Serum or Plasma
1656
16005
1.17
2.17
28.2
16.3
mmol/l
139.3
139.6
4.45
1628
15554
(3025941) Bacteria identified in Stool by Culture
116
889
1.32
2.17
1.4
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
242
1.62
2.16
1.4
1.1
iu/ml
367777.2
2266.3
—
6
58
(3000492) Spirometry study
181
1470
1.25
2.16
1.6
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
205
1689
1.24
2.15
1.3
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1362
12988
1.14
2.15
29.4
17.2
%
13.9
13.7
2.64
1340
12679
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
40
251
1.60
2.13
1.2
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
136
1069
1.29
2.12
3.7
2.9
e9/l
4.3
4.1
0.51
94
859
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
31
2.91
2.07
1.4
2.4
umol/l
21.4
18.3
—
9
31
(3012516) Albumin [Mass/volume] in Urine
484
4321
1.16
2.07
3.4
3.2
mg/l
53.6
297.7
4.24
326
2771
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
101
765
1.34
2.06
1.1
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
383
3361
1.17
2.05
1.9
1.7
pmol/l
444.1
25206889.8
2.62
331
2785
(3026389) Candida sp identified in Specimen by Organism specific culture
31
184
1.69
2.04
1.3
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
15
4.01
2.04
1.2
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1658
16049
1.16
2.03
28.2
16.5
mmol/l
3.9
4.0
6.19
1626
15568
(3035320) C reactive protein [Mass/volume] in Body fluid
21
111
1.90
2.01
4.0
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
155
1.75
2.00
1.3
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
15
70
2.15
1.98
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
305
2636
1.18
1.96
1.7
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
165
1343
1.25
1.95
5.6
3.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
11
4.55
1.94
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
11
4.55
1.94
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
85
2.01
1.90
1.2
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
34
2.65
1.86
4.8
2.5
mmol/l
1.2
1.2
—
9
34
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
174
1.68
1.86
2.6
4.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
76
561
1.37
1.85
2.2
3.3
u/ml
1554.2
7129.4
0.56
56
478
(3026480) Teichoate Ab [Titer] in Serum
5
12
4.17
1.82
1.2
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
12
4.17
1.82
12.0
1.9
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
298
0.53
1.76
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
80
601
1.34
1.76
2.0
2.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
18
3.34
1.74
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
31
194
1.61
1.71
1.2
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
194
1.61
1.71
1.2
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
25
148
1.70
1.70
2.5
2.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
17
89
1.92
1.70
1.1
1.0
ng/l
259.3
300.7
0.58
12
54
(3004451) EKG impression Narrative
15
75
2.01
1.69
1.6
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
82
1.96
1.69
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
82
1.96
1.69
1.1
1.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
187
1.61
1.69
1.3
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
19
3.16
1.66
1.7
1.7
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
17
90
1.90
1.65
1.1
1.0
ng/l
27.8
47.1
2.02
12
51
(3019225) pH of Specimen
181
1521
1.21
1.62
4.1
4.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
41
278
1.48
1.62
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
37
246
1.51
1.60
2.4
3.6
%
0.9
1.4
0.43
28
198
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1402
14512
0.90
1.58
4.4
3.8
mmol/l
1.4
1.3
5.63
1273
13282
(3020491) Glucose [Moles/volume] in Blood
20
114
1.76
1.56
2.4
1.7
mmol/l
7.7
6.8
0.49
15
73
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
107
1.78
1.54
1.7
2.1
e6/l
999.9
689.7
—
7
46
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1039
9859
1.11
1.54
3.6
3.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
71
1.98
1.54
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
71
1.98
1.54
1.4
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
169
1.61
1.52
1.3
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
153
1274
1.22
1.51
4.1
4.0
%
0.8
0.9
0.22
49
371
(3034860) Kappa light chains.free [Mass/volume] in Serum
62
460
1.36
1.51
1.8
3.4
mg/l
45.3
65.5
0.72
47
375
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
21
2.86
1.50
1.0
1.9
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
461
1.36
1.50
1.8
3.4
mg/l
38.5
43.0
0.21
47
377
(3017446) Testosterone [Moles/volume] in Serum or Plasma
126
1030
1.24
1.49
2.4
2.2
nmol/l
11.7
12.2
0.25
109
904
(4035726)
156
1304
1.21
1.49
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
126
1031
1.24
1.48
3.4
3.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
94
1.81
1.47
1.6
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
16
87
1.85
1.45
1.4
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
16
87
1.85
1.45
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
154
1290
1.21
1.45
4.3
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
140
1162
1.22
1.44
4.0
3.9
%
0.4
0.6
0.92
32
273
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
34
228
1.50
1.44
2.1
1.4
u/l
25.3
25.3
0.00
23
184
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
106
854
1.25
1.43
2.0
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
212
1.52
1.43
1.3
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
60
449
1.35
1.41
9.5
4.0
mg/l
1.6
1.6
0.08
52
417
(3024869) Neuronal Ab [Presence] in Serum
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
89
706
1.27
1.38
1.9
1.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
34
231
1.48
1.36
1.4
1.4
nmol/l
0.2
0.4
2.00
22
180
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
135
1.64
1.35
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
457
4180
1.12
1.34
5.0
3.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
10
47
2.13
1.33
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
46
333
1.39
1.33
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
79
621
1.28
1.32
7.6
5.8
%
2.0
1.6
1.67
73
576
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
20
121
1.66
1.30
1.3
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
18
106
1.70
1.29
1.6
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
34
2.36
1.29
1.1
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
161
1.56
1.28
2.3
2.3
umol/l
6.2
6.3
0.01
15
113
(3042631) Mycobacterium sp identified in Specimen
31
210
1.48
1.27
2.4
2.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
100
815
1.24
1.25
1.4
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
445
4835
0.90
1.23
4.5
5.0
ug/l
3.4
4.1
0.19
394
4290
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
139
1.59
1.23
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
22
139
1.59
1.23
1.1
1.2
nmol/l
339.2
380.7
0.41
15
125
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
19
2.63
1.21
2.0
1.5
umol/l
59.8
47.5
—
5
19
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
348
1.36
1.21
1.4
1.6
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
22
140
1.58
1.20
1.9
1.5
%
39.6
29.8
—
10
87
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
156
1.54
1.20
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
134
1132
1.20
1.19
4.3
4.1
%
0.1
0.6
0.66
36
289
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
12
64
1.88
1.18
1.3
1.3
%
72.0
60.7
0.60
12
48
(3007930) Methemoglobin/Hemoglobin.total in Blood
77
615
1.26
1.17
7.7
5.8
%
0.9
0.9
0.13
72
572
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
223
1.44
1.16
1.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
142
1209
1.19
1.16
4.3
4.0
%
0.2
0.1
0.25
41
343
(3008536) Aspergillus sp Ab [Presence] in Serum
0
35
0.00
1.15
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
58
1.90
1.12
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
21
135
1.56
1.11
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
51
1.96
1.11
2.5
1.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
375
3431
1.11
1.10
5.2
4.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
52
398
1.31
1.10
1.7
1.9
iu/l
2.8
4.6
1.75
16
133
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
66
1.82
1.09
2.1
4.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1490
14509
1.09
1.08
21.6
13.1
ml/min/173m2
84.5
80.6
8.84
1304
11954
(4133840)
7
32
2.19
1.08
1.6
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
261
1.39
1.07
1.3
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
354
3864
0.90
1.07
3.9
4.3
%
21.1
21.5
0.18
153
1895
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
17
105
1.62
1.06
1.6
1.3
u/l
13.4
14.3
0.17
17
98
(40760888) Immunoglobulin light chains.free panel - Serum
45
340
1.33
1.05
1.7
3.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
67
1.80
1.04
1.1
1.1
iu/ml
118.2
223.2
1.24
12
67
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
90
1.67
1.04
1.2
1.1
ratio
1.0
1.1
—
5
37
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
16
252
0.63
1.03
1.8
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
29
204
1.43
1.03
2.7
2.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
83
1.69
1.01
1.6
1.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
35
2.00
1.00
1.3
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
47
361
1.31
0.99
1.4
1.6
—
—
—
0
0
(3019977) pH of Arterial blood
13
76
1.71
0.99
1.6
3.4
ph
7.4
7.4
—
5
22
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
61
1.81
0.98
1.0
1.1
miu/ml
2370.4
1738.2
0.66
11
61
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
15
92
1.63
0.97
2.3
2.2
ug/min
131.7
255.2
—
6
18
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
81
668
1.22
0.96
1.9
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
210
1875
1.13
0.95
9.2
7.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
259
1.36
0.95
1.5
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
141
1.49
0.94
1.4
1.7
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
51
1.77
0.94
1.2
1.1
%
13.1
28.4
—
9
45
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
135
1.49
0.89
2.3
2.3
u/field
4.8
2.1
0.54
12
54
(3029075) Extractable nuclear Ab panel - Serum
8
42
1.91
0.88
1.4
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
119
1.52
0.88
1.1
1.2
u/ml
0.1
0.6
—
8
54
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
43
1.86
0.87
1.4
1.4
ug/l
10.6
9.1
—
8
43
(3052592) Norovirus Ag [Presence] in Stool
6
30
2.00
0.87
1.5
1.5
—
—
—
0
0
(4015189)
8
44
1.82
0.86
3.6
2.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
170
1.42
0.85
1.4
1.3
e6/l
14893.9
95748.7
1.24
16
101
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
72
1.67
0.85
3.4
2.9
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
31
1.94
0.84
1.3
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
261
0.69
0.82
1.4
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
46
1.74
0.82
1.4
1.4
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
41
320
1.29
0.80
1.6
2.0
nmol/l
0.9
0.9
0.23
30
266
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1462
14928
0.93
0.80
5.1
4.4
mmol/l
6.0
5.9
1.87
1314
13561
(3005033) Fetal Nuchal fold Thickness US
18
259
0.69
0.80
1.4
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
58
1.73
0.79
3.6
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
41
321
1.28
0.79
1.4
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
270
0.70
0.79
1.5
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
33
1.82
0.79
1.7
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
190
1.37
0.79
1.2
1.4
mmol/l
7.2
7.4
0.10
16
135
(40768793) Breast Pathology biopsy report
27
360
0.75
0.77
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
115
1.48
0.76
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
91
1.54
0.75
1.4
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
91
1.54
0.75
1.4
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
24
2.09
0.74
1.6
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
24
2.09
0.74
1.2
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
9
54
1.67
0.74
1.3
1.3
%
1.7
2.9
—
9
46
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
38
1.84
0.73
3.1
1.9
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
5
25
2.00
0.72
1.6
1.0
ng/l
30.0
142.8
—
5
16
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
356
0.76
0.72
5.5
3.6
mg/l
29.9
26.8
0.13
19
230
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
20
276
0.72
0.72
1.7
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
84
1.55
0.71
1.2
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
33
255
1.30
0.71
1.4
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
76
1.58
0.71
1.5
1.4
pmol/l
83.2
392.5
—
5
28
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
26
1.92
0.70
1.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
64
537
1.20
0.69
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
23
169
1.36
0.69
1.1
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
519
0.81
0.69
1.6
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
27
1.85
0.68
1.6
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
44
540
0.81
0.68
1.6
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
41
329
1.25
0.68
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
25
188
1.33
0.66
1.5
1.3
e6/l
1792.9
1573.6
0.14
20
131
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
28
1.79
0.66
5.2
6.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
31
241
1.29
0.66
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
78
1.54
0.65
2.7
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
590
0.83
0.64
1.4
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
114
0.61
0.58
1.4
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
36
1.67
0.56
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
36
1.67
0.56
1.2
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
44
526
0.83
0.55
1.7
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
37
1.62
0.55
1.5
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
37
1.62
0.55
5.2
6.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
19
251
0.75
0.55
4.7
3.9
u/ml
26.4
31.9
0.20
19
242
(3036071) Salmonella sp Ab [Titer] in Serum
9
61
1.48
0.53
1.1
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
100
1.40
0.51
1.2
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
144
1.32
0.50
1.1
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
31
252
1.23
0.49
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
84
1.43
0.49
1.2
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
45
1.56
0.49
2.0
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
178
0.73
0.48
2.9
2.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
46
1.52
0.48
1.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
7
47
1.49
0.47
1.4
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
89
796
1.12
0.47
4.3
3.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
37
309
1.20
0.47
2.7
3.5
e9/l
4.0
4.3
0.18
37
309
(3044007) Cell count panel - Peritoneal fluid
7
48
1.46
0.46
1.3
2.0
—
—
—
0
0
(44806420)
7
48
1.46
0.46
1.9
2.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
47
402
1.17
0.46
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
132
1438
0.91
0.45
1.3
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
82
0.61
0.45
1.8
2.0
ug/l
4.6
2.9
—
5
71
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
84
0.59
0.45
1.0
1.1
—
—
—
0
0
(44813793)
14
103
1.36
0.45
1.1
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
38
320
1.19
0.44
2.7
3.9
%
57.8
57.7
0.01
38
320
(3033799) Differential panel - Peritoneal fluid
7
51
1.37
0.44
1.9
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
28
229
1.23
0.43
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
166
1.27
0.43
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
11
78
1.41
0.43
1.5
2.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
31
1.61
0.43
1.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
265
2797
0.94
0.42
2.6
3.1
ug/l
0.7
0.8
0.32
195
1866
(44790048)
21
167
1.26
0.41
1.4
1.5
—
—
—
0
0
(44790049)
21
167
1.26
0.41
1.4
1.5
—
—
—
0
0
(44790047)
21
167
1.26
0.41
1.4
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
30
249
1.21
0.41
1.2
1.2
u/l
27.7
37.2
0.40
25
215
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
206
0.77
0.41
1.3
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
43
370
1.17
0.41
2.3
2.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.40
0.0
4.7
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
18
0.00
0.40
0.0
1.0
—
9.0
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
35
1.43
0.39
5.4
6.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
35
1.43
0.39
1.6
2.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
24
196
1.23
0.39
2.7
2.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
11
80
1.38
0.38
1.1
1.7
—
10.4
—
0
7
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1430
14114
1.04
0.37
6.6
5.6
mmol/mol
40.3
39.8
0.63
1333
13040
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
116
1.29
0.37
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1636
16513
0.96
0.36
14.5
10.1
u/l
26.4
26.0
0.49
1585
15920
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
168
0.77
0.35
1.2
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
42
1.43
0.35
1.5
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
42
1.43
0.35
1.5
2.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
13
99
1.31
0.35
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
80
0.62
0.35
1.8
2.0
ug/l
1.9
1.9
—
5
67
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
135
1.26
0.35
3.4
4.8
u/ml
293.6
65.3
—
6
41
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
46
1.30
0.33
1.2
1.3
%
37.2
56.2
—
6
40
(3042733) HLA Ab [Presence] in Serum
6
47
1.28
0.32
3.5
4.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(4281824)
13
165
0.79
0.32
1.5
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1446
14295
1.04
0.32
27.5
15.2
%
39.3
39.5
0.62
1037
10308
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
30
348
0.86
0.31
1.5
1.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
42
370
1.14
0.31
2.5
2.4
ug/min
173.0
136.4
0.19
23
226
(3043410) Blood group antigens tested for on Red Blood Cells
7
54
1.30
0.30
1.6
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
131
1228
1.07
0.30
2.8
2.7
ml/min/173m2
66.8
66.4
0.04
62
499
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
196
0.81
0.30
1.1
1.0
u/ml
4.7
2.6
—
9
76
(3025130) Human papilloma virus identified in Specimen
23
194
1.19
0.29
2.0
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
28
323
0.86
0.28
1.3
1.4
—
—
—
0
0
(44806118)
20
167
1.20
0.28
1.5
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
8
63
1.27
0.27
1.1
1.2
umol/l
3.3
5.1
—
8
57
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
28
322
0.87
0.27
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
28
322
0.87
0.27
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
35
309
1.13
0.27
1.6
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
28
321
0.87
0.26
1.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
61
558
1.10
0.26
2.7
3.3
g/l
0.2
0.3
2.07
30
227
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
22
188
1.17
0.25
1.2
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
74
1.22
0.25
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
74
1.22
0.25
1.4
1.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1340
13259
1.03
0.25
31.1
18.2
g/l
331.7
332.2
1.14
1325
13126
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
114
1.23
0.25
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
148
0.81
0.24
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
20
170
1.18
0.24
1.5
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
170
1.18
0.24
1.5
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
78
1.28
0.24
1.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
38
1.32
0.23
1.2
1.8
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
178
0.84
0.22
1.1
1.1
u/ml
3.4
4.2
—
8
74
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
10
0.00
0.21
0.0
2.1
—
0.3
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
4575.2
—
0
5
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
11
0.00
0.21
0.0
1.8
—
2.4
—
0
11
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
12
98
1.23
0.21
1.2
1.3
—
211.1
—
0
9
(3025018) Bordetella pertussis Ab [Titer] in Serum
12
98
1.23
0.21
1.3
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
145
1.17
0.20
1.2
1.4
e6/l
99017.5
134274.7
0.16
12
102
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
6
49
1.22
0.20
1.3
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
49
1.22
0.20
1.2
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
50
1.20
0.19
1.7
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
302
0.89
0.19
1.9
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
20
174
1.15
0.19
1.7
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
90
1.22
0.19
1.2
1.7
mmol/l
7.8
7.7
—
6
54
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
52
1.15
0.19
1.3
1.2
%
118.5
114.1
—
6
44
(3048929) Epstein Barr virus Ab [Presence] in Serum
50
463
1.08
0.18
1.6
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
11
91
1.21
0.17
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
132
1266
1.05
0.17
1.5
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
110
1.18
0.17
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
15
129
1.16
0.17
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
15
129
1.16
0.17
1.3
1.4
mmol/l
12.4
11.9
—
6
36
(4211845)
5
70
0.71
0.16
3.6
2.7
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1642
16498
0.98
0.16
26.8
16.4
umol/l
76.8
78.0
0.59
1642
16491
(1617658) Protocol used for examination of sentinel lymph nodes
11
130
0.85
0.16
1.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
111
1.17
0.15
1.2
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
15
130
1.15
0.15
3.4
2.1
—
1.6
—
0
9
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
7
86
0.81
0.14
7.6
6.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
23
254
0.90
0.14
1.3
1.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
424
4166
1.02
0.14
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
44
414
1.06
0.12
5.8
4.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
30
279
1.08
0.11
1.1
1.1
u/ml
0.1
2.3
2.52
13
124
(3038026) Centromere Ab [Units/volume] in Serum
13
115
1.13
0.10
1.2
1.1
—
75.9
—
0
7
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19
208
0.91
0.10
2.4
2.3
u/ml
4082.1
25.4
0.76
19
197
(3035933) Granulocytes/100 leukocytes in Blood
5
45
1.11
0.09
1.0
2.2
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
47
1.06
0.09
1.6
3.4
—
36.2
—
0
7
(3027456) Digoxin [Moles/volume] in Serum or Plasma
34
360
0.94
0.09
3.5
3.1
nmol/l
0.7
0.9
1.22
26
285
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
20
184
1.09
0.09
1.4
2.2
pg
31.9
32.3
0.16
20
184
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
6
55
1.09
0.09
1.7
4.1
mg/l
9.0
7.8
—
6
49
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
204
1.08
0.08
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
62
0.81
0.08
1.0
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
62
0.81
0.08
3.6
2.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
16
146
1.10
0.08
1.6
2.2
—
—
—
0
0
(4146454)
15
164
0.91
0.08
2.7
2.7
—
—
—
0
0
(3000012) Reticulocyte production index
8
76
1.05
0.07
1.6
1.8
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
7
81
0.86
0.07
1.3
1.1
—
1.6
—
0
22
(3044242) Glucose [Moles/volume] in Arterial blood
9
88
1.02
0.07
1.8
2.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
61
591
1.03
0.06
1.4
1.7
mg/l
4.1
3.9
0.03
46
418
(3003740) Influenza virus B Ag [Presence] in Specimen
28
266
1.05
0.06
1.2
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1626
16291
0.99
0.05
21.0
13.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
167
1648
1.01
0.05
1.6
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
26
248
1.05
0.05
1.0
1.1
u/ml
0.7
4.6
3.96
18
128
(3000034) Microalbumin [Mass/volume] in Urine
14
130
1.08
0.04
2.2
3.1
mg/l
38.4
40.8
—
8
98
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
181
1831
0.99
0.04
4.7
4.3
%
31.2
32.5
0.78
129
1234
(3012441) Differential panel - Pleural fluid
18
170
1.06
0.04
1.5
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
169
0.95
0.03
1.3
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
132
1.06
0.02
1.6
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
142
1.06
0.02
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
142
1.06
0.02
1.3
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
12
113
1.06
0.01
1.3
1.1
—
36.3
—
0
6
(3002256) Pathology report gross observation
200
1989
1.01
0.01
1.2
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
114
1.05
0.00
2.4
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
12
114
1.05
0.00
1.2
1.1
—
50.1
—
0
10
(3004775) Volume in Urine collected for unspecified duration
12
116
1.03
0.00
2.1
2.3
ml
796.6
652.2
—
7
70
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
232
0.99
0.00
1.1
1.1
u/ml
4.2
2.3
—
6
60
(3002523) Influenza virus A Ag [Presence] in Specimen
27
266
1.01
0.00
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
108
1.02
0.00
1.1
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
152
0.99
0.00
1.3
1.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
11
106
1.04
0.00
1.1
1.1
—
2.2
—
0
6
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
241
2413
1.00
0.00
1.4
1.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
24
239
1.00
0.00
1.0
1.1
u/ml
0.4
2.0
1.39
13
109
(3038177) Helicobacter pylori Ab [Presence] in Serum
24
242
0.99
0.00
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
285
0.98
0.00
1.8
1.3
u/ml
216.8
265.4
0.43
21
166
(3050129) First trimester maternal screen panel - Serum or Plasma
38
379
1.00
0.00
1.3
1.4
—
—
—
0
0
(4034850)
52
516
1.01
0.00
12.0
10.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
128
1.02
0.00
1.5
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
128
1.02
0.00
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
128
1.02
0.00
1.5
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
47
470
1.00
0.00
1.3
1.3
miu/ml
189.0
231.7
0.28
17
216
(3022475) Manganese [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
0.1
—
0
9
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
7
0.00
0.00
0.0
1.1
—
7.7
—
0
7
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
89
0.90
0.00
1.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.0
—
0
7
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1483.0
—
0
6
(46236302) HLA-C [Type] by High resolution typing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.6
1.6
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
59
0.85
0.00
1.6
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.6
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
2.7
—
4.3
—
0
6
(40763590) HLA-DQ beta [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
66
0.91
0.00
1.5
2.0
ug/l
24.2
138.0
—
6
58
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.6
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.6
1.6
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013862) HLA-DP [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
1.5
—
0
5
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
9
89
1.01
0.00
1.1
1.5
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.0
—
394.4
—
0
7
(3015183) Erythrocyte sedimentation rate
8
83
0.96
0.00
1.1
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_HEMIPLE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HEMIPLE | 2.657 [2.41, 2.93] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.197 |
During the follow-up period (1.1.1998 — 31.12.2019), 2893 out of 7556 females with G6_HEMIPLE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_HEMIPLE | 2.42 [2.19, 2.68] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 3188 out of 6891 males with G6_HEMIPLE died.
Mortality risk
Mortality risk for people of age
years, who have G6_HEMIPLE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.253% | 0.489% |
| 5 | 1.566% | 2.915% |
| 10 | 3.809% | 6.952% |
| 15 | 7.185% | 13.236% |
| 20 | 12.133% | 21.79% |
Relationships between endpoints
↥Index endpoint: G6_HEMIPLE – Hemiplegia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data